Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E26.51 EPS (ttm)0.97 Insider Own0.50% Shs Outstand2.53B Perf Week-3.40%
Market Cap65.32B Forward P/E14.03 EPS next Y1.84 Insider Trans0.00% Shs Float2.50B Perf Month-6.92%
Income2.47B PEG- EPS next Q0.59 Inst Own13.90% Short Float1.23% Perf Quarter-21.97%
Sales23.82B P/S2.74 EPS this Y128.90% Inst Trans13.51% Short Ratio4.96 Perf Half Y-12.35%
Book/sh5.17 P/B4.99 EPS next Y-10.90% ROA3.90% Target Price34.12 Perf Year-20.37%
Cash/sh1.58 P/C16.34 EPS next 5Y-1.00% ROE16.50% 52W Range25.76 - 34.58 Perf YTD-20.44%
Dividend0.90 P/FCF- EPS past 5Y-16.70% ROI11.50% 52W High-25.33% Beta0.75
Dividend %3.49% Quick Ratio0.70 Sales past 5Y-5.80% Gross Margin82.70% 52W Low0.23% ATR0.55
Employees61500 Current Ratio0.80 Sales Q/Q-4.10% Oper. Margin14.50% RSI (14)28.59 Volatility1.53% 1.54%
OptionableYes Debt/Eq1.35 EPS Q/Q31.60% Profit Margin10.40% Rel Volume1.28 Prev Close25.89
ShortableYes LT Debt/Eq1.13 EarningsNov 10 BMO Payout143.60% Avg Volume6.21M Price25.82
Recom2.20 SMA20-5.04% SMA50-12.54% SMA200-13.73% Volume7,943,769 Change-0.27%
Nov-25-16Upgrade Liberum Hold → Buy
Sep-23-16Initiated Piper Jaffray Overweight
Sep-12-16Upgrade Jefferies Hold → Buy
Aug-29-16Upgrade Argus Hold → Buy
Jul-12-16Initiated Argus Hold
Apr-12-16Downgrade Goldman Neutral → Sell
Mar-15-16Downgrade Jefferies Buy → Hold
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-08-16Downgrade HSBC Securities Buy → Hold
Jan-19-16Upgrade Barclays Underweight → Equal Weight
Dec-01-15Upgrade Morgan Stanley Underweight → Overweight
Nov-02-15Downgrade Nordea Buy → Hold
Oct-20-15Downgrade Credit Suisse Neutral → Underperform
Sep-18-15Upgrade Bryan Garnier Neutral → Buy
Jul-31-15Upgrade Swedbank Neutral → Buy
Jul-02-15Upgrade Berenberg Hold → Buy
Apr-15-15Initiated Societe Generale Buy
Sep-22-10Reiterated Barclays Capital Equal Weight $225 → $230
Jul-29-10Downgrade Standpoint Research Buy → Hold $60
Jun-30-10Upgrade Jefferies Underperform → Hold
Dec-05-16 04:04PM  FitBit, Teva Slide into Mondays 52-Week Low Club at 24/7 Wall St.
12:21PM  Is Diageo plc (ADR) (DEO) A Good Stock To Buy? at Insider Monkey
12:21PM  Early Data Demonstrate Clinical Activity of Acalabrutinib in Difficult-to-Treat Chronic Lymphocytic Leukemia Business Wire
Dec-02-16 08:04AM  Keytruda Is Mercks Immuno-Oncology Business
06:40AM  Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytruda
Dec-01-16 10:04AM  How Much Could Gilead Sciencess Revenues Fall beyond 2016?
09:30AM  Is Celgene Corporation (CELG) Worthy of Your Portfolio? at Insider Monkey
07:42AM  AstraZeneca in broad drug deal with Bicycle worth up to $1 bln Reuters
Nov-30-16 11:02AM  3 Horrible Stocks for Retirees at Motley Fool
Nov-28-16 08:49AM  Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALIOF
Nov-25-16 08:49AM  AstraZeneca upgraded by Liberum
Nov-24-16 01:54PM  Should You Light Up An Investment In Reynolds American, Inc. (RAI)? at Insider Monkey
07:13AM  GSK chases Astra with start of big anaemia drug trials Reuters
Nov-23-16 04:57PM  AstraZeneca: Nexium Pay-For-Delay Win Upheld (AZN) at Investopedia
11:05AM  AstraZeneca PLC (ADR) (AZN), Ranbaxy Laboratories Limited (ADR) (RBXLY) Wins Over Illegal Deal Case at Insider Monkey
07:59AM  Allergan Acquires Chase Pharma, Expands CNS Portfolio
05:42AM  AstraZeneca: FDA Lifts Hold on Head & Neck Cancer Trials
Nov-22-16 06:04PM  These Will Be the Challenges to BMYs Opdivo in the Lung Cancer Space
04:04PM  AstraZeneca, Novartis Drop into Tuesdays 52-Week Low Club
03:42PM  Is This Drug Inovio Pharmaceuticals' Best Chance for Success? at Motley Fool
02:32PM  Inside Bristol-Myers Squibbs Upward Revision of Guidance
01:12PM  [$$] AstraZeneca given green light to resume cancer drug trials at Financial Times
09:00AM  Glaxo Files for COPD Drug; FluLaval Approved for Infants
03:56AM  AstraZeneca cleared to resume enrolment in cancer drug trials Reuters
02:28AM  U.S. FDA lifts hold on AstraZeneca head and neck cancer trials Reuters
Nov-21-16 11:04AM  Why Is Lung Cancer so Attractive to Bristol, Merck, and Roche?
10:04AM  Brace Yourself: AstraZeneca Could Be a Fourth Entrant into the PD-1/PD-L1 Drug Class
08:46AM  $13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market at Motley Fool
07:40AM  Here's Why Immune Design Should Be in Your Portfolio Now
Nov-18-16 05:04PM  Understanding Bristols Blockbuster: Opdivos Edge over Keytruda
04:49PM  Bristol Myers Squibb Co. (BMY), Alkermes Plc (ALKS) & More: How Opus Points Bet on Healthcare Sector Paid Off? at Insider Monkey
04:04PM  Opdivos Approval for Head and Neck Cancer: Another Feather in Bristols Cap?
Nov-16-16 12:43PM  ETFs with exposure to AstraZeneca Plc : November 16, 2016
Nov-15-16 01:55PM  These Drugs Led Medicare Spending (GILD, SNY) at Investopedia
10:04AM  AstraZenecas Other Products in 3Q16
08:04AM  Inside AstraZenecas Oncology Segment Growth in 3Q15
07:52AM  Ironwood (IRWD) Presents Positive Phase III Data on Zurampic
Nov-14-16 05:41PM  AstraZeneca's Symbicort Positive in Pediatric Asthma Study
11:04AM  Why AstraZenecas Respiratory Segment Is a Key Growth Platform
10:04AM  Understanding the Revenue Fall in AstraZenecas Largest Segment in 3Q16
09:51AM  AstraZeneca Plc :AZN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
09:19AM  5 Pharma Stocks in Focus on World Diabetes Day
08:04AM  The Performance of AstraZenecas Growth Platforms in 3Q16
Nov-13-16 09:28PM  New Pharma Rankings On Global Access To Medicine at Forbes
Nov-12-16 08:16AM  The Potential and Peril with Inovio Pharmaceuticals, Inc. at Motley Fool
Nov-11-16 06:04PM  Inside AstraZenecas Revenue Fall in 3Q16
03:52PM  AstraZenecas Valuation and 3Q16 Earnings
12:50PM  AstraZeneca PLC (ADR) (AZN) Retreats On Some Durvalumab Plans at Insider Monkey
08:55AM  Pharma Stock Roundup: Pharma Stocks Rally on Trump Win, Pfizer to Divest Consumer Unit?
08:49AM  AstraZeneca (AZN) Beats on Q3 Earnings; Sales Slow Down
08:00AM  AstraZeneca Announces Study Results Show SYMBICORT Improves Lung Function in Pediatric Asthma Patients Business Wire
12:04AM  [$$] AstraZeneca Profit Lifted by Tax Gain at The Wall Street Journal
Nov-10-16 10:11AM  [$$] AstraZeneca: Trump lifts it up at Financial Times
08:34AM  [$$] AstraZeneca revenues dented by generic rivals at Financial Times
08:27AM  Here's Why AstraZeneca Dipped 14.2% in October at Motley Fool
07:49AM  European Markets Higher As Global 'Trump Rally' Continues
07:39AM  AstraZeneca Stocks Slips as Third-Quarter Crestor Sales, Earnings Disappoint
07:18AM  Drug firm AstraZeneca sees 3rd quarter earnings fall 12 pct
06:56AM  AstraZeneca sees big healthcare changes under Trump Reuters
05:43AM  [$$] AstraZeneca Profit Lifted by Tax Gain at The Wall Street Journal
05:22AM  Astrazeneca beats 3Q profit forecasts
03:56AM  AstraZeneca drops early head and neck cancer drug plans Reuters
03:19AM  Tax gain and cost cuts help AstraZeneca offset flagging Crestor Reuters
02:17AM  AstraZeneca's drug sales weighed on by flagging Crestor
Nov-09-16 03:08PM  Look at This Number in Inovio Pharmaceuticals' Q3 Results and Forget the Rest at Motley Fool
12:08AM  [$$] AstraZeneca walks tightrope of drug trials at Financial Times
Nov-08-16 01:27PM  [$$] AstraZeneca Earnings: What to Watch at The Wall Street Journal
10:04AM  What Are Valeants Potential Growth Drivers?
Nov-07-16 11:05AM  This Contributed to Pfizers Growth in 3Q16
Nov-04-16 01:03PM  Alexion Soars, Then Falls Amid Takeover Rumors
Nov-03-16 04:27PM  How Could a Potential Nexium Lawsuit Affect AstraZeneca?
03:04PM  What Might Have Fueled Valeants Interest in Salix?
Nov-01-16 01:00PM  [$$] Pfizer cancels cholesterol drug trial and cuts earnings forecast at Financial Times
08:04AM  Behind the Recent Developments in Pfizers 3Q16 Estimates
Oct-31-16 10:04AM  Januvia and Janumet: Mercks Blockbuster Diabetes Products
10:04AM  Talazoparib and Pidilizumab May Prove Complementary to Pfizers Existing Oncology Drugs
Oct-30-16 02:33PM  5 Trade Ideas for Monday: AstraZeneca, Fortinet, Home Bancshares, Honeywell and Northern Trust
Oct-28-16 03:04PM  Keytruda: The New Blockbuster of Mercks Immuno-Oncology Franchise
10:04AM  Pfizer Aims to Position Avelumab as Backbone Immuno-Oncology Therapy
09:25AM  Pharma Stock Roundup: Bristol-Myers, Merck Top Estimates, Merck Wins Key FDA Nod
08:00AM  New Data Shows Frequent ICU Admissions from Severe RSV Disease among Preterm Infants in the First Three Months of Life Business Wire
04:28AM  FDA Pauses Two AstraZeneca Cancer Studies (AZN) at Investopedia
Oct-27-16 08:23PM  PRESS DIGEST- Financial Times - Oct 28 Reuters
02:11PM  [$$] FDA deals blow to AstraZeneca cancer drug at Financial Times
01:14PM  [$$] AstraZeneca Suspends Recruitment in Two Cancer Clinical Trials at The Wall Street Journal
12:56PM  [$$] AstraZeneca slides after cancer drug trial suspended at Financial Times
10:02AM  AstraZeneca PLC (ADR) (AZN) Unveils Positive SOLO-2 Data at Insider Monkey
Oct-26-16 04:36PM  Tesaro's Ovarian Cancer Drug Has Edge Vs. AstraZeneca's: Analyst
07:40AM  AstraZeneca Is Now a Competitive Threat to Tesaro in Ovarian Cancer Maintenance Therapy
07:16AM  Puts showing caution in AstraZeneca
07:15AM  Myriads BRACAnalysis CDx® Test Identifies Patients with Ovarian Cancer Who Would Benefit from Second-Line Maintenance Treatment with Olaparib GlobeNewswire
07:00AM  LYNPARZATM (olaparib) Phase III SOLO-2 Trial Shows Significant Progression-Free Survival Benefit Business Wire
Oct-24-16 08:05AM  Allergan to Present New Data from its Anti-Infectives Portfolio at IDWeek 2016 in New Orleans PR Newswire
Oct-21-16 11:01AM  Here's how a $50 drug ends up costing you $700 in America's healthcare system
Oct-20-16 10:00AM  Cloud-Centered IT Transformation At AstraZeneca at Forbes
Oct-19-16 01:19PM  Drug Wars: California Vote Could Limit Price Hikes at Investopedia
09:56AM  AstraZeneca's Hyperkalemia Drug NDA Resubmission Accepted
Oct-18-16 12:39PM  AstraZeneca Plc : AZN-US: Dividend Analysis : August 12th, 2016 (record date) : By the numbers : October 18, 2016
Oct-17-16 07:30AM  White House To Announce Big Push For Cancer Blood Tests at Forbes
Oct-15-16 05:11PM  How the Opioid Epidemic Is Changing 2 Drugmakers' Fortunes at Motley Fool
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of respiratory, inflammation, autoimmune, cardiovascular, metabolic, oncology, infection, neuroscience, and gastrointestinal diseases worldwide. Its marketed products comprise Accolate, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp, Duaklir Genuair, Eklira Genuair/Tudorza/Bretaris, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Rhinocort, Symbicort pMDI, and Symbicort Turbuhaler for respiratory, inflammation, and autoimmunity diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL, Tenormin3, and Zestril4 for cardiovascular disease; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic disease. The company's marketed products also include Arimidex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex, as well as Casodex, Cosudex for oncology disease; Fluenz/FluMist, Fluenz Tetra/FluMist Quadrivalent1, Merrem/Meronem2, Synagis3, and Zinforo4 for infection disease; Diprivan, EMLA, Movantik/Moventig, Naropin, Seroquel IR, Seroquel XR, Vimovo1, Xylocaine, and Zomig for neuroscience disease; and Losec/Prilosec and Nexium for gastrointestinal disease. It primarily serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 146 projects, of which 125 are in the clinical phase of development. It has collaboration agreements with Celgene Corporation; Immunocore Limited; Eli Lilly and Company; Heptares Ltd.; Foundation Medicine, Inc., French National Institute of Health and Medical Research (Inserm); and FibroGen and Astellas. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in London, the United Kingdom.
EBAY eBay Inc. daily Stock Chart
EBAY [NASD]
eBay Inc.
IndexS&P 500 P/E17.79 EPS (ttm)1.59 Insider Own6.60% Shs Outstand1.08B Perf Week-0.77%
Market Cap30.54B Forward P/E13.59 EPS next Y2.09 Insider Trans-0.47% Shs Float1.04B Perf Month1.03%
Income1.86B PEG2.31 EPS next Q0.54 Inst Own86.00% Short Float1.60% Perf Quarter-12.53%
Sales8.91B P/S3.43 EPS this Y330.80% Inst Trans0.32% Short Ratio1.59 Perf Half Y16.76%
Book/sh6.06 P/B4.68 EPS next Y10.84% ROA9.30% Target Price32.58 Perf Year-3.41%
Cash/sh7.44 P/C3.81 EPS next 5Y7.70% ROE27.60% 52W Range21.52 - 33.19 Perf YTD3.17%
Dividend- P/FCF11.63 EPS past 5Y3.30% ROI13.00% 52W High-14.58% Beta1.28
Dividend %- Quick Ratio2.60 Sales past 5Y-1.30% Gross Margin78.00% 52W Low31.74% ATR0.61
Employees11600 Current Ratio2.60 Sales Q/Q5.60% Oper. Margin26.40% RSI (14)44.29 Volatility2.55% 2.19%
OptionableYes Debt/Eq1.32 EPS Q/Q-17.60% Profit Margin20.30% Rel Volume1.02 Prev Close28.42
ShortableYes LT Debt/Eq1.11 EarningsJan 18 AMC Payout0.00% Avg Volume10.52M Price28.35
Recom2.60 SMA20-0.21% SMA50-4.99% SMA2004.07% Volume10,723,468 Change-0.25%
Oct-21-16Upgrade Hilliard Lyons Long-term Buy → Buy
Oct-20-16Reiterated Wedbush Neutral $34 → $33
Oct-20-16Reiterated Mizuho Neutral $31 → $32
Oct-18-16Reiterated Monness Crespi & Hardt Buy $32 → $35
Oct-17-16Reiterated The Benchmark Company Buy $33 → $38
Oct-13-16Resumed Wedbush Neutral $34
Sep-29-16Upgrade Deutsche Bank Hold → Buy $30 → $40
Sep-14-16Reiterated Axiom Capital Buy $34 → $38
Sep-13-16Reiterated Axiom Capital Buy $34 → $38
Aug-30-16Initiated Hilliard Lyons Long-term Buy $35
Jul-21-16Reiterated The Benchmark Company Buy $29 → $33
Jul-21-16Reiterated RBC Capital Mkts Sector Perform $28 → $31
Jul-21-16Reiterated Monness Crespi & Hardt Buy $29 → $32
Jul-21-16Reiterated Mizuho Neutral $26 → $31
Jul-21-16Reiterated Canaccord Genuity Hold $27 → $28
Jul-21-16Reiterated Axiom Capital Buy $30 → $34
Jun-23-16Initiated Maxim Group Buy $36
Apr-27-16Reiterated RBC Capital Mkts Sector Perform $29 → $28
Apr-19-16Downgrade Morgan Stanley Equal-Weight → Underweight
Mar-29-16Downgrade Barclays Equal Weight → Underweight $28 → $25
Dec-05-16 03:00AM  Holiday Sales May Be Not So Merry for Retailers (AMZN, WMT) at Investopedia
Dec-02-16 05:09PM  Neiman Marcus Debenture Bonds Yielding 8%
11:18AM  Beware scammers as you chase the year's hottest toy at CNBC
08:55AM  Detroit's Rockbridge Growth Equity Announces Sale Of Triad Retail Media To Xaxis
Dec-01-16 12:09PM  U.S. software group CA buys Austrian peer Automic in 600 mln euro deal
08:15AM  Cyber Monday Was Top Online Sales Day Ever
Nov-30-16 11:38AM  Ebay is analyzing your facial expressions to decide what you want for Christmas at CNBC
Nov-29-16 03:23PM  Going Beyond Good To Become Great at Forbes
01:57PM  Amazon Set To Wage War On Counterfeits at Investopedia
08:21AM  Groupon Divests Malaysia Business, Restructuring On Track
08:00AM  eBay Celebrates #GivingTuesday With Hundreds of Unique Items and Experiences, Helping Shoppers Find Perfect Gifts That Give Back Business Wire
Nov-28-16 11:57AM  Shoppers spend more online
Nov-27-16 08:03PM  Should You Add LIBERTY GLOBAL PLC (LBTYK) to Your Portfolio? at Insider Monkey
Nov-26-16 02:01PM  Hatchimals hottest in Christmas toy hunt AAP
01:49PM  CNBC stood in line for 18 hours for Snap's Spectacles. Here's what we thought of them. at CNBC
Nov-25-16 07:28AM  How the popularity of gift cards underscores Americas loss of civility at MarketWatch
Nov-24-16 09:14PM  These brothers are going to make thousands of dollars after correctly predicting the hottest holiday toy
02:20PM  Best Black Friday Deals 2016: Walmart, Target, Best Buy, Amazon, on TVs, Toys and More at Barrons.com
Nov-23-16 04:27PM  These ETFs are a play on millennial spending habits at MarketWatch
01:09PM  The Black Friday shopping frenzy is moving further online
12:00PM  More and More Hedge Funds Are Selling eBay Inc (EBAY) at Insider Monkey
08:08AM  On BizWireTV: Black Friday Shopping Expected to Break Records and the Worlds Largest Digital Safety Platform Business Wire
05:17AM  Strategies for shopping on Black Friday at MarketWatch
Nov-22-16 03:20PM  eBay 'Black Friday' 2016 Deals: How Good Are They? at Forbes
07:00AM  EBay Wants to Make Mobile Wednesday a Thing. Good Luck With That at Bloomberg
05:12AM  NFL, suffering from sagging attendance, loses yet another battle at MarketWatch
12:06AM  Snapchat Spectacles Take Video, Cover Mortgage Payments at The Wall Street Journal
Nov-21-16 04:27PM  Kanye West's Canceled Tour Means A Lot Of Lost Ticket Sales
04:25PM  The Website That's Turning Pawn Shopping On Its Head
12:43PM  Snapchat's Spectacles Arrive in New York Just in Time for the Holidays
11:02AM  Bob Peck: Holiday Shopping Forecast Suggests Amazon, eBay Will Meet Estimates
10:46AM  Billionaire John Paulsons Most Bullish Q3 Moves: Biogen (BIIB), eBay Inc. (EBAY) & More at Insider Monkey
Nov-18-16 09:37PM  eBay Stock Hasn't Recovered Since Earnings, Will This Slump Continue?
03:41PM  Goldman Sachs has an idea for how to make money this holiday season at CNBC
01:43PM  Top Research Reports for Cisco, Amgen & NextEra Energy
Nov-17-16 09:06AM  Free mobile service FreedomPop enters refurbished phone market
09:00AM  eBay Makes the Holidays More Social, Helping Shoppers Find Perfect Presents and Achieve Their #GiftGoals Business Wire
Nov-16-16 08:15PM  Better Buy: eBay Inc. vs. PayPal at Motley Fool
04:25PM  Buying Snapchats Spectacles may require a last-minute trip across the country at MarketWatch
10:06AM  Steve Mandel Expands Consumer Cyclical Empire in 3rd Quarter
09:11AM  Nintendo Mini NES: Can't Get Your Hands On This Year's Hottest Gift? Neither Could We
03:00AM  Amazon Sues Counterfeit Sellers (AMZN, BABA) at Investopedia
Nov-15-16 08:33PM  By Suing Over Counterfeits, Amazon is Putting Standards Ahead of Short-Term Growth
03:28PM  What To Do When You Have Bad News at Forbes
02:00PM  Let This Fund Manager Be Your 'Arbiter' of Value
09:00AM  The number of workers joining the gig economy has slowed dramatically, study says at CNBC
09:00AM  StubHub Becomes Official Ticket Partner at TD Place Business Wire
04:26AM  Snapchats $130 video recording Spectacles are being sold online for $5,000 at CNBC
Nov-14-16 01:17PM  Should You Invest in eBay Inc (EBAY), Zayo Group Holdings Inc (ZAYO) & Two Other Stocks? at Insider Monkey
12:14PM  Why You Should Consider Investing in Delphi Automotive PLC (DLPH), Tempur Sealy International Inc (TPX), & Two Other Stocks at Insider Monkey
Nov-11-16 10:42AM  People are selling Nintendo's new $60 console for ridiculous amounts of money
Nov-10-16 04:37PM  U.S. Ecommerce Strong, but Southeast Asia Stronger
03:10PM  Amazon's Stock May Be Suffering From the Trump Effect
11:00AM  BigCommerce and eBay Deliver Solution for Omni-Channel Selling Business Wire
10:20AM  Cook, Zuckerberg, other tech execs reassure workers about Trump at bizjournals.com
09:02AM  Trending Stocks: Lockheed Martin to Get Trump Boost? Plus the Latest on ConocoPhillips, Netflix, Pfizer, and More at Insider Monkey
Nov-08-16 01:23PM  eBay Runs Its First Holiday Season TV Commercials at Investopedia
07:40AM  Albany tech company inks new deal with Dick's Sporting Goods at bizjournals.com
Nov-07-16 09:50AM  How Klarna Plans To Replace Your Credit Card at Forbes
09:00AM  eBays New Holiday Campaign Captures the Emotion and Excitement of Giving the Perfect Gift Business Wire
08:34AM  Here's How eBay Is Looking To Tap Facebook Users at Forbes
07:10AM  There Could Be A Major Shift To Online Sales This Black Friday -- Is Walmart Set To Benefit? at Forbes
Nov-05-16 08:30AM  You can buy a Florida voting machine from the 2000 election on eBay
Nov-04-16 12:51PM  MercadoLibre Earnings: Stock Has 25% Upside, Credit Suisse Says at Barrons.com
Nov-03-16 07:17PM  [$$] EBay Boosts Earnings View Due to Sale of More MercadoLibre Shares at The Wall Street Journal
05:33PM  EBay raises guidance on additional Mercado Libre stock sale at MarketWatch
05:11PM  EBAY INC Files SEC form 8-K, Regulation FD Disclosure
05:09PM  Bullish On eBay at Forbes
04:40PM  MercadoLibre Q3 Earnings, Revenue Beat Estimates
10:27AM  Watch These Amazon Competitors Ahead of Black Friday, and After It
09:30AM  Better Buy: eBay Inc vs. Overstock.com, Inc. at Motley Fool
01:33AM  [$$] Google set to hit back at Brussels over competition probe at Financial Times
Nov-02-16 02:24PM  The hottest toy this holiday season just hatched at CNBC
09:00AM  eBay Inc. Recommends Shareholders Reject Mini-Tender Offer by TRC Capital Corporation Business Wire
Nov-01-16 04:45PM  Airbnb Will Store Personal Data of China Users Locally
03:39PM  T.J. Maxx Versus Retail and Resale
03:15PM  Facebook Investors Can Expect Another Dominant Quarter at TheStreet
01:23PM  Jerome Dodson Comments on eBay
01:00PM  Gifter or Grinch: eBay Motors Reveals One-Third of Consumers Gift Vehicles Thoughtfully Business Wire
12:19PM  How Does LivingSocial Fit into Groupons Strategy?
11:13AM  [$$] Instagram adds ecommerce services to attract retailers at Financial Times
11:00AM  Facebook Faces Tough Comparisons, So Beware at TheStreet
06:10AM  [$$] Don't Cry for EBay's $1.37 Billion Argentine Sale at Barrons.com
Oct-28-16 12:54PM  Amazon Offers High Value Potential to Investors
Oct-27-16 01:26PM  From retail to resale: FedEx Office's eBay Valet centers in full swing at bizjournals.com
10:23AM  Groupon (GRPN) Posts Narrower-than-Expected Loss in Q3
09:00AM  Sell These 5 Stocks Now Before its Too Late
Oct-26-16 01:04PM  EBAY INC Financials
10:00AM  Groupon is a Clear Short Candidate this Earnings Season
09:00AM  5 Stocks to Watch After the Market Closes Today
Oct-25-16 05:19PM  PayPal: The Way of the Future
03:41PM  Potoo: The Company Tracking Counterfeits on Amazon at MarketWatch
02:42PM  ETFs with exposure to eBay, Inc. : October 25, 2016
07:16AM  Is eBay getting ready to fall further?
05:58AM  Competition heats up in emerging markets at MarketWatch
Oct-24-16 10:05AM  eBay, Inc. :EBAY-US: Earnings Analysis: Q3, 2016 By the Numbers : October 24, 2016
10:04AM  eBays Rising Sales Fail to Lift Profits
08:05AM  Why Analysts Now See eBay and PayPal in Such Different Situations at 24/7 Wall St.
06:31AM  World Series ticket mania
Oct-21-16 04:43PM  [$$] PayPal shares extend 2016 gains on robust revenue outlook at Financial Times
eBay Inc. operates e-commerce platforms that connect various buyers and sellers worldwide. Its platforms enable sellers to organize and offer inventory for sale; and buyers to find and buy it virtually anytime and anywhere. The company's Marketplace platforms include its online marketplace at ebay.com and the eBay mobile apps; and StubHub platforms comprise its online ticket platform at stubhub.com and the StubHub mobile apps, which enable fans to purchase tickets to the games, concerts, and theater shows. Its Classifieds platforms include a collection of brands, such as Mobile.de, Kijiji, Gumtree, Marktplaats, eBay Classifieds, and others that offer online classifieds and help people find whatever they are looking for in their local communities. The company platforms enable users to find, buy, sell, and pay for items through various online, mobile, and offline channels, which include retailers, distributors, liquidators, import and export companies, auctioneers, catalog and mail-order companies, classifieds, directories, search engines, commerce participants, shopping channels, and networks. eBay Inc. was founded in 1995 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Doerger Brian J.VP, Chief Accounting OfficerNov 21Option Exercise22.8818,000411,87644,826Nov 23 07:13 PM
Doerger Brian J.VP, Chief Accounting OfficerNov 21Sale28.9318,000520,79626,826Nov 23 07:13 PM
Green LoganDirectorNov 02Buy28.321,00028,3211,000Nov 03 08:02 PM
FISHER STEPHENSVP, CTOOct 25Option Exercise21.6412,408268,532120,563Oct 26 07:50 PM
FISHER STEPHENSVP, CTOOct 25Sale29.2039,7641,161,10986,258Oct 26 07:50 PM
FISHER STEPHENSVP, CTOOct 15Option Exercise0.00106,5490169,212Oct 17 06:42 PM
Schenkel Scott F.SVP, Chief Financial OfficerOct 15Option Exercise0.005,9070100,848Oct 17 06:37 PM
WENIG DEVINPresident and CEOOct 15Option Exercise0.0013,8980466,832Oct 17 06:32 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerSep 15Option Exercise0.005,731035,051Sep 19 05:54 PM
Lee Jae HyunSVP, Asia PacificSep 15Option Exercise0.003,126088,096Sep 19 05:49 PM
Lawton III Harry ASVP, North AmericaSep 15Option Exercise0.003,647028,081Sep 19 05:44 PM
Huber Marie OhSVP, GC and SecretarySep 15Option Exercise0.002,500020,883Sep 19 05:32 PM
FISHER STEPHENSVP, CTOSep 15Option Exercise0.007,294066,470Sep 19 05:22 PM
Doerger Brian J.VP, Chief Accounting OfficerSep 15Option Exercise0.004,558029,205Sep 19 05:16 PM
Yetto Kristin ASVP, Chief People OfficerSep 15Option Exercise0.003,126022,472Sep 19 06:23 PM
Todd Jeremy PaulSVP, EMEASep 15Option Exercise0.002,084068,280Sep 19 06:06 PM
Schenkel Scott F.SVP, Chief Financial OfficerSep 15Option Exercise0.006,252098,204Sep 19 06:00 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerAug 31Option Exercise22.7141,880951,13948,779Sep 01 05:49 PM
Lee Jae HyunSVP, Asia PacificAug 31Sale31.8516,559527,42684,970Sep 02 04:58 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerAug 31Sale32.1439,0301,254,56526,980Sep 01 05:49 PM
SWAN ROBERT HOLMESDirectorAug 30Sale31.9550,0001,597,500375,928Sep 01 05:27 PM
Lee Jae HyunSVP, Asia PacificAug 24Sale31.025,625174,488101,529Aug 26 06:40 PM
Todd Jeremy PaulSVP, EMEAAug 10Option Exercise0.0032,935084,065Aug 12 05:06 PM
Lee Jae HyunSVP, Asia PacificJul 27Sale31.533,222101,590107,154Jul 28 08:15 PM
Lee Jae HyunSVP, Asia PacificJul 26Sale31.0310,601328,949110,376Jul 27 06:40 PM
FISHER STEPHENSVP, CTOJul 25Option Exercise21.6437,223805,57797,032Jul 27 06:58 PM
TIERNEY THOMAS JDirectorJul 25Option Exercise9.858,00078,80025,545Jul 27 07:13 PM
Doerger Brian J.VP, Chief Accounting OfficerJul 25Option Exercise22.6313,608307,94948,605Jul 27 06:19 PM
Lee Jae HyunSVP, Asia PacificJul 25Sale30.741,16735,878120,977Jul 27 06:40 PM
Yetto Kristin ASVP, Chief People OfficerJul 25Sale30.7917,596541,83419,346Jul 27 06:34 PM
Doerger Brian J.VP, Chief Accounting OfficerJul 25Sale30.5623,958732,26424,647Jul 27 06:19 PM
SWAN ROBERT HOLMESDirectorJul 25Sale30.6550,0001,532,340425,288Jul 27 07:06 PM
FISHER STEPHENSVP, CTOJul 25Sale30.6553,3891,636,16959,176Jul 27 06:58 PM
TIERNEY THOMAS JDirectorJul 25Sale30.658,000245,20017,545Jul 27 07:13 PM
Schenkel Scott F.SVP, Chief Financial OfficerJul 17Option Exercise0.001,768092,875Jul 18 08:27 PM
WENIG DEVINPresident and CEOJul 17Option Exercise0.005,8950449,754Jul 18 07:55 PM
Lawton III Harry ASVP, N.A.Jun 15Option Exercise0.0042,723039,075Jun 17 07:57 PM
Lee Jae HyunSVP, Asia PacificJun 15Option Exercise0.003,1270122,144Jun 17 07:53 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerJun 15Option Exercise0.005,732029,461Jun 17 07:50 PM
Doerger Brian J.VP, Chief Accounting OfficerJun 15Option Exercise0.004,559037,376Jun 17 07:46 PM
Todd Jeremy PaulSVP, EMEAJun 15Option Exercise0.0014,501057,098Jun 17 07:42 PM
WENIG DEVINPresident and CEOJun 15Option Exercise0.0013,0870450,688Jun 17 08:18 PM
Schenkel Scott F.SVP, Chief Financial OfficerJun 15Option Exercise0.006,253094,370Jun 17 08:15 PM
Huber Marie OhSVP, GC & SecretaryJun 15Option Exercise0.0031,556029,055Jun 17 08:10 PM
Yetto Kristin ASVP, Chief People OfficerJun 15Option Exercise0.0015,543041,926Jun 17 08:04 PM
FISHER STEPHENSVP, CTOJun 15Option Exercise0.007,295079,149Jun 16 08:42 PM
Doerger Brian J.VP, Chief Accounting OfficerJun 08Option Exercise0.0011,388038,760Jun 09 05:22 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMay 27Sale24.2425,000605,89823,729Jun 01 04:28 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 24Option Exercise16.6814,474241,42641,846May 24 08:58 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 24Sale24.0814,474348,53427,372May 24 08:58 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 09Option Exercise16.6820,000333,60047,372May 10 07:49 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 09Sale24.0320,000480,65027,372May 10 07:49 PM
Yetto Kristin ASVP, Chief People OfficerApr 29Sale24.1110,630256,30428,343May 03 07:29 PM
Yetto Kristin ASVP, Chief People OfficerApr 01Option Exercise0.0027,861052,553Apr 05 08:01 PM
WENIG DEVINPresident and CEOApr 01Option Exercise0.0078,0130477,120Apr 05 07:59 PM
Todd Jeremy PaulSVP, EMEAApr 01Option Exercise0.0017,168052,659Apr 05 07:49 PM
Schenkel Scott F.SVP, Chief Financial OfficerApr 01Option Exercise0.0025,0330100,013Apr 05 07:48 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerApr 01Option Exercise0.0010,973053,026Apr 05 07:47 PM
Lee Jae HyunSVP, Asia PacificApr 01Option Exercise0.0016,1830117,850Apr 05 07:36 PM
FISHER STEPHENSVP, CTOApr 01Option Exercise0.0010,919077,552Apr 05 07:35 PM
Doerger Brian J.VP, Chief Accounting OfficerApr 01Option Exercise0.0025,327036,892Apr 05 07:33 PM
PITTMAN RAYMOND JSVP, Chief Product Officer,Feb 26Option Exercise20.9428,204590,592111,323Mar 01 06:53 PM
PITTMAN RAYMOND JSVP, Chief Product Officer,Feb 26Sale24.3378,5371,910,77232,786Mar 01 06:53 PM
TIERNEY THOMAS JDirectorFeb 17Option Exercise6.694,42429,59719,901Feb 18 07:01 PM
TIERNEY THOMAS JDirectorFeb 17Sale23.084,424102,10615,477Feb 18 07:01 PM
TIERNEY THOMAS JDirectorFeb 16Option Exercise6.693,57623,92319,053Feb 18 07:01 PM
TIERNEY THOMAS JDirectorFeb 16Sale23.003,57682,24815,477Feb 18 07:01 PM
PRESSLER PAUL SDirectorFeb 01Buy23.944,180100,05410,448Mar 04 08:16 PM
SWAN ROBERT HOLMESDirectorFeb 01Sale23.7450,0001,187,065474,469Feb 03 05:23 PM
Doerger Brian J.VP, Chief Accounting OfficerDec 15Option Exercise0.0013,928018,833Dec 17 07:02 PM
PITTMAN RAYMOND JSVP, Chief Product Officer, MaDec 15Option Exercise0.00131,9130149,518Dec 17 06:42 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E20.84 EPS (ttm)1.23 Insider Own0.10% Shs Outstand2.11B Perf Week0.43%
Market Cap53.93B Forward P/E18.17 EPS next Y1.41 Insider Trans0.19% Shs Float1.41B Perf Month2.49%
Income2.53B PEG3.69 EPS next Q0.32 Inst Own36.20% Short Float0.49% Perf Quarter-5.93%
Sales22.70B P/S2.38 EPS this Y-14.40% Inst Trans1.04% Short Ratio1.43 Perf Half Y-11.59%
Book/sh10.40 P/B2.46 EPS next Y12.48% ROA5.00% Target Price32.07 Perf Year11.43%
Cash/sh0.03 P/C944.51 EPS next 5Y5.65% ROE11.90% 52W Range19.00 - 30.10 Perf YTD-0.12%
Dividend1.62 P/FCF- EPS past 5Y16.90% ROI8.30% 52W High-15.12% Beta0.92
Dividend %6.34% Quick Ratio0.50 Sales past 5Y-4.30% Gross Margin15.10% 52W Low34.47% ATR0.58
Employees6800 Current Ratio0.80 Sales Q/Q-6.10% Oper. Margin15.80% RSI (14)49.15 Volatility2.25% 2.00%
OptionableYes Debt/Eq1.10 EPS Q/Q-6.80% Profit Margin11.10% Rel Volume0.51 Prev Close25.38
ShortableYes LT Debt/Eq0.97 EarningsOct 27 BMO Payout129.20% Avg Volume4.86M Price25.55
Recom1.70 SMA200.80% SMA50-2.29% SMA200-3.62% Volume2,489,692 Change0.67%
Nov-16-16Initiated Ladenburg Thalmann Buy
Sep-30-16Initiated Mizuho Buy $32
Sep-19-16Upgrade Credit Suisse Neutral → Outperform
Aug-31-16Reiterated Wunderlich Buy $33 → $32
Aug-18-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-11-16Initiated Bernstein Outperform $33
Apr-29-16Downgrade Seaport Global Securities Buy → Neutral $30
Jan-20-16Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-06-16Initiated Scotia Howard Weil Sector Outperform $31
Nov-03-15Reiterated Argus Buy $44 → $38
Jul-31-15Reiterated Stifel Buy $38 → $34
Jul-23-15Initiated DA Davidson Buy $36
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Jan-20-15Reiterated Oppenheimer Outperform $44 → $39
Jun-03-14Initiated Global Hunter Securities Buy $83
May-02-14Reiterated Stifel Buy $75 → $78
May-02-14Reiterated RBC Capital Mkts Outperform $71 → $80
May-02-14Reiterated Oppenheimer Outperform $74 → $86
Dec-05-16 09:21AM  4 winning investment moves for the Trump tax era at CNBC
08:55AM  Enterprise Products Partners to Present at Wells Fargo Pipeline, MLP and Utility Symposium Business Wire
Dec-04-16 05:06PM  The Secret Behind Enterprise's Falling Price (EPD) at Investopedia
05:37AM  5 Dividend Stocks to Buy in December at Motley Fool
Dec-02-16 03:04PM  Analyzing the Recent Trends in MLP Equity Issuance
02:40PM  Enterprise Did Not Respond Well to OPEC News (EPD) at Investopedia
Dec-01-16 05:51PM  More and More Hedge Funds Love Enterprise Products Partners L.P. (EPD) at Insider Monkey
Nov-30-16 10:17AM  Which Energy Company Is the Best Dividend Stock? at Motley Fool
08:04AM  What Does the MLP Funds Market Look Like?
Nov-28-16 10:50AM  3 High-Yield Dividend Stocks for Retirement at Kiplinger
Nov-26-16 06:03PM  Enterprise Dips Despite Strong Fundamentals (EPD) at Investopedia
08:45AM  Oil Rig Count Rises by 3; OPEC Supply Cut Talks Flounder
Nov-25-16 12:59PM  First Trust MLP and Energy Income Fund Announces Monthly Dividend
Nov-24-16 02:58PM  Enterprise Products Partners L.P. (EPD): How Safe Is This High-Yield MLPs Distribution? at Insider Monkey
Nov-23-16 10:30AM  How Do Midstream Stocks with Higher Implied Volatility Move?
08:19AM  EPD: A Good Company with Dangerous Stock Chart (EPD) at Investopedia
Nov-22-16 04:04PM  Why ETP Decided to Merge into Sunoco Logistics Partners
09:09AM  Analyzing US Crude Oil Movement by Rail in August
08:04AM  Capital Projects Should Continue to Drive ONEOKs Growth in 2017
Nov-19-16 08:10PM  Weekly Top Insider Buys Highlight for Week of Nov. 18
Nov-18-16 08:04AM  Dominion Midstream Targets Annual Distribution Growth of 22%
Nov-17-16 08:30AM  Enterprise Products Among Most Honored Companies in Institutional Investors 2017 All-America Executive Team Business Wire
Nov-16-16 05:39PM  Is Enterprise Attractive in This Oil Market? (EPD) at Investopedia
10:04AM  How Much Have MLP Fund Inflows Improved in 2016?
08:04AM  What Are Institutional Investors Doing with Their EEP Holdings?
07:01AM  Coverage initiated on Enterprise Products by Ladenburg Thalmann
Nov-15-16 10:32AM  Returns of Midstream Stocks with High and Low Implied Volatilities
Nov-14-16 07:14PM  Cramer warns to stay on the sidelines for this group, thanks to Trump at CNBC
11:43AM  These 3 Hated Dividend Stocks Are Buys at Motley Fool
Nov-12-16 08:42AM  Rig Count Ticks Down as Crude, Natural Gas Prices Plunge at 24/7 Wall St.
Nov-11-16 04:30PM  Enterprise Products Partners to Participate in Investor Conferences Business Wire
Nov-10-16 01:04PM  ENTERPRISE PRODUCTS PARTNERS L P Financials
10:52AM  How Could Trumps Victory Affect Your MLP Investments?
Nov-08-16 04:33PM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements
04:15PM  Weitzel Elected to Enterprise Board of Directors Business Wire
Nov-04-16 06:05AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 10-Q, Quarterly Report
Nov-03-16 10:15AM  Enterprise Products Partners (EPD) Q3 Earnings in Line
08:25AM  Enterprise Products Sends Bearish Signals (EPD) at Investopedia
Nov-02-16 03:25PM  What Drove ONEOKs 3Q16 Earnings Growth?
08:10AM  7 Top Stocks to Buy in November at Motley Fool
Nov-01-16 11:12AM  Sea Change: Midstream Oil And Gas Sector M&A Reshaped By Downturn at Forbes
06:35AM  Enterprise Products Stock Lures Big Buyers (EPD) at Investopedia
Oct-31-16 01:32PM  ETFs with exposure to Enterprise Products Partners LP : October 31, 2016
Oct-28-16 05:49PM  Stifel Sees MLP 'Healing' and 'Green Shoots' in EPD Earnings at Barrons.com
05:04PM  EPDs 3Q16 Results: Is a Recovery in Energy Coming Soon?
02:55PM  Why Enterprise Products Partners 3Q16 Earnings Fell
10:00AM  Enterprise Stock Dip No Cause for Alarm (EPD) at Investopedia
09:50AM  Enterprise Products Partners' Third Quarter Remains Consistent at Motley Fool
09:40AM  Can Any Energy Stock Break Out Now? (FANG, EPD) at Investopedia
09:29AM  Enterprise Products Partners LP :EPD-US: Earnings Analysis: Q3, 2016 By the Numbers : October 28, 2016
Oct-27-16 03:36PM  Edited Transcript of EPD earnings conference call or presentation 27-Oct-16 2:00pm GMT
02:04PM  Enterprise Products' Q3 Earnings Fail to Wow Investors at Barrons.com
11:20AM  Enterprise Products (EPD) Stock Lower After Q3 Results
10:00AM  Enterprise Products Partners LP Earnings Call scheduled for 10:00 am ET today
08:04AM  58% of Analysts Rate PAA as a Hold ahead of Its 3Q16 Results
07:07AM  Q3 2016 Enterprise Products Partners LP Earnings Release - Before Market Open
06:06AM  Enterprise Products meets 3Q profit forecasts
06:03AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Fin
06:00AM  Enterprise Reports Results for Third Quarter 2016 Business Wire
Oct-26-16 12:24PM  How Will Enterprise Products (EPD) Stock React to Thursday's Q3 Earnings?
09:01AM  Can Xerox (XRX) Spring a Surprise this Earnings Season?
08:51AM  Should You Buy Enterprise Products (EPD) Ahead of Earnings?
Oct-25-16 04:04PM  Why Plains All American Has Outperformed Its Peers in 2016
11:04AM  Magellan Midstream Trades at a Lower Yield Than Its Peers
08:05AM  How Most Analysts See Magellan ahead of Its 3Q16 Results
06:36AM  EQT Corp (EQT): A Beat in Store this Earnings Season?
Oct-24-16 06:04PM  A Look at Magellans Debt Position
04:11PM  Enterprise's Seaway Crude pipeline system shut after Cushing, Oklahoma spill
01:09PM  [$$] Seaway leak helps send US oil below $50 at Financial Times
12:52PM  [$$] Seaway Says Two Pipelines Shut Because of Oil Spill at The Wall Street Journal
11:46AM  Enterprise Has Solid Asset Base for Income (EPD) at Investopedia
08:48AM  Enterprise Products Partners LP breached its 50 day moving average in a Bearish Manner : EPD-US : October 24, 2016
Oct-22-16 09:10AM  Rising Rig Count, Continuing Crude Glut Weighs on Price at 24/7 Wall St.
Oct-21-16 04:04PM  ETP, EEP, and WPZ: Are the Attractive Yields Worth the Risk?
12:26PM  Magellan Midstream Partners Increases 3Q16 Distributions by 2%
09:09AM  Hess Corp (HES): What's in Store this Earnings Season?
Oct-20-16 11:17PM  MLP 'Game of Tones' Continues as Q3 Earnings Roll Out: 6 Themes at Barrons.com
03:40PM  How Pipeline Investment Write-Downs Affected KMI in 3Q16
09:28AM  What's in Store for Valero Energy (VLO) in Q3 Earnings?
09:04AM  [$$] India's Reliance Industries Profit Falls 23% at The Wall Street Journal
Oct-19-16 11:52AM  ETFs with exposure to Enterprise Products Partners LP : October 19, 2016
08:04AM  How Analysts Rate Enterprise Products before Its 3Q16 Results
Oct-18-16 11:04AM  What Will Drive Enterprise Products Partners Future Growth?
10:04AM  A Look at Enterprise Products Partners Leverage
08:58AM  Returns of High and Low Implied Volatility Midstream Stocks
08:04AM  Gas Gathering, Processing Now Contribute Less to EPDs Earnings
Oct-17-16 11:05AM  How Are EPDs Segments Expected to Perform in 3Q16?
10:05AM  EPD Has $5.6 Billion in Capital Projects Under Construction
09:32AM  Can Kinder Morgan (KMI) Pull a Surprise in Q3 Earnings?
08:05AM  Enterprise Products Is Expected To Report Flat 3Q16 Earnings
Oct-15-16 09:25AM  Rising Rig Count Stifles Crude Oil Price Gains as Hedge Fund Short-Covering Ends at 24/7 Wall St.
Oct-13-16 11:36AM  What Analysts Already Think about Kinder Morgans 3Q Performance
09:34AM  US Crude Oil Movement by Rail Fell Slightly in July 2016
09:27AM  3 Energy Stocks We Can't Help but Love at Motley Fool
08:04AM  Comparing PAAs Earnings Multiples with Its Peers
Oct-12-16 11:04AM  Acquisitions Continue to Play a Role in PAAs Expansion Plans
Oct-11-16 04:53PM  The Process Of Speculation Updated at Forbes
09:30AM  The Zacks Analyst Blog Highlights: Alphabet, Novo Nordisk, Enterprise Products Partners, Textron and Xerox
08:22AM  Enterprise Products Partners LP breached its 50 day moving average in a Bullish Manner : EPD-US : October 11, 2016
Oct-10-16 01:57PM  Top Research Reports for Alphabet, Novo Nordisk & Enterprise Products
Enterprise Products Partners L.P., a master limited partnership, provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services segments. The NGL Pipelines & Services segment provides natural gas processing and related NGL marketing services, as well as NGL export docks and related services. It operates approximately 19,500 miles of NGL pipelines; NGL and related product storage facilities; 15 NGL fractionators; and a liquefied petroleum gas export terminal and NGL import facility. The Crude Oil Pipelines & Services segment operates approximately 5,400 miles of crude oil pipelines and related operations; and crude oil storage and marine terminals located in Oklahoma and Texas, as well as a fleet of 478 tractor-trailer tank trucks used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates approximately 19,100 miles of natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. It leases underground salt dome natural gas storage facilities in Texas and Louisiana; owns an underground salt dome storage cavern in Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 674 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities. It also operates refined products pipelines of approximately 4,200 miles; and terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARTH CARIN MARCYDirectorNov 16Buy25.274,000101,08013,126Nov 16 04:50 PM
BARTH CARIN MARCYDirectorFeb 12Buy20.525,000102,6005,000Feb 17 04:06 PM
MCMAHEN CHARLES EDirectorFeb 12Buy19.9910,000199,90097,554Feb 12 04:13 PM
Montgomery William CDirectorFeb 11Buy19.6910,000196,90036,500Feb 11 06:48 PM
WILLIAMS RANDA DUNCANDirectorJan 04Buy26.113,830,256100,007,9843,330,619Jan 04 05:47 PM
ANDRESS THURMONDirectorDec 22Buy25.102,50062,74247,552Dec 22 06:20 PM
TEAGUE AJChief Operating OfficerDec 07Buy21.307,040149,952469,493Dec 07 04:26 PM
TEAGUE AJChief Operating OfficerDec 07Buy21.2923,475499,7831,389,300Dec 07 04:26 PM
Montgomery William CDirectorDec 07Buy21.2510,000212,50026,500Dec 07 04:15 PM
FOWLER W RANDALLChief Administrative OfficerDec 07Buy21.515,000107,550741,083Dec 07 04:08 PM
VRX Valeant Pharmaceuticals International, Inc. daily Stock Chart
VRX [NYSE]
Valeant Pharmaceuticals International, Inc.
Index- P/E- EPS (ttm)-6.49 Insider Own2.30% Shs Outstand337.90M Perf Week-12.04%
Market Cap5.18B Forward P/E2.91 EPS next Y5.27 Insider Trans2.78% Shs Float332.43M Perf Month-20.60%
Income-2256.30M PEG- EPS next Q1.22 Inst Own66.80% Short Float8.73% Perf Quarter-47.95%
Sales10.01B P/S0.52 EPS this Y-133.00% Inst Trans20.92% Short Ratio1.61 Perf Half Y-37.74%
Book/sh11.92 P/B1.29 EPS next Y-3.11% ROA-4.70% Target Price24.66 Perf Year-83.91%
Cash/sh1.95 P/C7.87 EPS next 5Y11.07% ROE-42.90% 52W Range13.77 - 119.87 Perf YTD-84.91%
Dividend- P/FCF13.35 EPS past 5Y4.40% ROI3.70% 52W High-87.20% Beta-0.12
Dividend %- Quick Ratio1.10 Sales past 5Y54.60% Gross Margin73.80% 52W Low11.40% ATR1.37
Employees22000 Current Ratio1.50 Sales Q/Q-11.00% Oper. Margin-5.20% RSI (14)34.54 Volatility5.69% 7.77%
OptionableYes Debt/Eq7.31 EPS Q/Q- Profit Margin-22.50% Rel Volume0.65 Prev Close15.45
ShortableYes LT Debt/Eq7.29 EarningsNov 08 BMO Payout- Avg Volume18.09M Price15.34
Recom3.00 SMA20-11.08% SMA50-25.84% SMA200-47.44% Volume11,755,101 Change-0.71%
Nov-23-16Downgrade Mizuho Neutral → Underperform $25 → $11
Nov-14-16Reiterated Deutsche Bank Hold $29 → $24
Nov-10-16Reiterated Morgan Stanley Overweight $42 → $25
Nov-10-16Downgrade Rodman & Renshaw Buy → Neutral $81 → $23
Nov-09-16Reiterated RBC Capital Mkts Sector Perform $35 → $29
Oct-14-16Reiterated Deutsche Bank Hold $30 → $29
Oct-12-16Reiterated RBC Capital Mkts Sector Perform $36 → $35
Sep-20-16Resumed Deutsche Bank Hold $30
Aug-17-16Upgrade Morgan Stanley Equal-Weight → Overweight $33 → $42
Aug-15-16Upgrade Mizuho Underperform → Neutral $11 → $25
Aug-10-16Reiterated RBC Capital Mkts Sector Perform $31 → $36
Aug-10-16Reiterated Piper Jaffray Underweight $19 → $22
Aug-09-16Reiterated Rodman & Renshaw Buy $90 → $81
Jun-23-16Downgrade JP Morgan Overweight → Neutral
Jun-08-16Reiterated Stifel Buy $65 → $55
Jun-08-16Reiterated RBC Capital Mkts Sector Perform $58 → $33
Jun-08-16Reiterated Mizuho Underperform $18 → $11
May-03-16Reiterated Rodman & Renshaw Buy $105 → $102
Apr-12-16Reiterated RBC Capital Mkts Sector Perform $69 → $65
Apr-11-16Reiterated Rodman & Renshaw Buy $118 → $105
Dec-05-16 12:48PM  3 Prime Reasons Valeant Pharmaceuticals Intl. Inc. Shares Dove 11% in November at Motley Fool
12:25PM  Can Donald Trump Make Valeant Stock Great Again? (VRX, XLV) at Investopedia
Dec-04-16 05:12PM  Is Valeant Pharmaceuticals Intl Inc (VRX) A Good Stock To Buy? at Insider Monkey
06:49AM  Is Mylan Being Really Smart -- Or Really Arrogant? at Motley Fool
Dec-02-16 06:06PM  [$$] Week in Review, December 2 at Financial Times
11:04AM  Analysts Are Bullish on Valeant
11:00AM  Bill Ackmans Biggest Q3 Moves As He Seeks Elusive Turnaround at Insider Monkey
10:07AM  Ackman Scores Big November on Fannie, Freddie Gains at The Wall Street Journal
10:04AM  Is Valeant Exposed to Default Risk?
08:04AM  Yes, There Will Be Margin Erosion for Valeant in 2017
Dec-01-16 11:04AM  Whats Forcing Valeant to Sell Its Core Assets?
10:47AM  3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017 at Motley Fool
10:05AM  How Does Valeant Plan to Resume Growth beyond 2016?
08:11AM  Chou Associates REALLY Loves Its Portfolio, Because It Didnt Touch It Last Quarter at Insider Monkey
08:05AM  Why Wasnt Valeants Enormous Growth Sustainable?
08:02AM  Ranking the Activists for Proxy Season 2016
07:06AM  Valeant Stock Plunges 11% on Failed Salix Sale (VRX) at Investopedia
06:49AM  Is Computer Sciences Corporation (CSC) A Good Stock To Buy? at Insider Monkey
Nov-30-16 06:47PM  SEC Discloses Correspondence Over Valeant's Accounting Practices -7.98%
05:41PM  SEC Again Criticizes Valeant Over Non-GAAP Financial Measures at The Wall Street Journal
05:04PM  Why Valeant Pharmaceuticals, Costamare, and First Bancorp Slumped Today at Motley Fool
05:03PM  Valeant-Takeda Salix Negotiations Bust On $10 Billion Price: Report
04:49PM  Valeant slumps 8% after talks to sell stomach-drug unit fall apart at CNBC
04:10PM  Valeant, Salix, Sales Force and Asset Sales
03:04PM  When Will Valeant Resume Its Top Line Growth?
02:50PM  Valeant: First No Salix Sale, Now the SEC Sees Accounting Issues?!?! at Barrons.com
02:44PM  Dow Climbs as Crude Rally Lights Fire Under Energy Sector, S&P 500 Falls
01:04PM  What Does Valeants Institutional Ownership Look Like?
01:04PM  How to Trade Wednesday's Most Active Stocks -- Chesapeake Energy, American Eagle, More
12:40PM  Valeant and Tribune Media Rebounds Not in Sight
12:34PM  Takeda's talks to acquire Valeant's Salix stall-sources
12:21PM  [$$] Valeant's talks to sell Salix unit for $10bn break down at Financial Times
11:54AM  Valeant Said to Plan to Keep Salix After Takeda Deal Falls Apart
11:54AM  Valeant Said to Keep Salix After Takeda Deal Falls Apart at Bloomberg
11:49AM  Why Valeant is Crumbling at Barrons.com
11:04AM  Has Valeant Really Bottomed Out?
10:58AM  Valeant Plummets on Reports of Salix Takeover Breakdown
10:34AM  Valeant Drops After Report Salix Sale Discussions Broke Down
10:18AM  It looks like a key Valeant deal might be falling apart, and now the stock is tanking
09:40AM  Uh Oh, Valeant's Hiring. Why That's Very Bad News. at Barrons.com
08:32AM  Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor
Nov-29-16 04:03PM  Mallinckrodt Earnings Top, But Stock Dives On Guidance
04:01PM  Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan® And Relistor® PR Newswire
04:01PM  Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan® And Relistor® CNW Group
11:05AM  What Do Analysts Have to Say about Mallinckrodt?
10:01AM  Valeant: Rooting For a Salix Sale? at Barrons.com
Nov-28-16 06:25PM  Mallinckrodts Greater Dependence on Acthar and Generic Business
Nov-27-16 04:54PM  Why Mallinckrodt Is Trading at a Discount on PE Basis
04:54PM  Behind Mallinckrodts Performance Based on EV-to-EBITDA
Nov-26-16 01:45PM  Smart Money is Pouring Into NetApp Inc. (NTAP) at Insider Monkey
Nov-25-16 08:44PM  Valeant Stock Could Fall 35%: Analyst (VRX) at Investopedia
Nov-24-16 11:02AM  3 Stocks That Have Been Complete Turkeys in 2016 at Motley Fool
Nov-23-16 09:39PM  Bill Miller Likes Buffetts Timing On Airlines, Talks Valeant (VRX)s Free Cash Flow, Amazon (AMZN)s Fate Under Trump at Insider Monkey
03:18PM  Eli Lilly: What Really Ails Big Pharma at The Wall Street Journal
12:10PM  [$$] Four traders exit Paulson & Co's London office at Financial Times
08:47AM  Valeant Pharma downgraded by Mizuho
Nov-22-16 03:27PM  Are These Criminal Charges the Nail in Valeant's Coffin? at Motley Fool
08:59AM  Index-Fund Bans and Hedge-Fund Data at Bloomberg
12:05AM  [$$] Valuation Experts Will Be Held to a New Standard at The Wall Street Journal
Nov-21-16 01:19PM  5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them at Motley Fool
10:43AM  Valeant Stock Attracting More Short Sellers (VRX) at Investopedia
08:12AM  Vetr Thinks Regeneron Is Looking Healthy
08:00AM  Valeant's Asset Sale Clock is Ticking at Bloomberg
01:00AM  Pharming Announces Financing Plans for Closing of RUCONEST® North American Rights Acquisition PR Newswire
Nov-18-16 02:55PM  Is Valeant Pharmaceuticals the Turnaround Opportunity of a Lifetime? at Motley Fool
12:45PM  Criminal Charges Against Former Valeant Exec 'Not Pertinent But Underscores Cautious Outlook'
11:57AM  Valeant and Philidor After the Criminal Charges
11:22AM  Valeant: The Shorts Are Back in Town at Barrons.com
07:49AM  Valeant Suffers From Too Much Legal Risk: Wells Fargo (VRX) at Investopedia
07:45AM  Does Valeant's Bad News Even Matter Anymore? at Motley Fool
12:23AM  [$$] U.S. Attorney Charges Former Valeant, Philidor Executives, Alleging Fraud and Kickback Scheme at The Wall Street Journal
Nov-17-16 08:22PM  [$$] U.S. Prosecutors Charge Former Valeant, Philidor Executives at The Wall Street Journal
07:27PM  Money in Medicine: The 30 drug and device makers who paid Oregon doctors the most at bizjournals.com
06:10PM  'Charged with a crime for doing his job': VALEANT DUO FIGHTS BACK
04:56PM  Ex-Valeant, Philidor execs arrested for fraud, conspiracy
04:13PM  Valeant's Pharmacy Ties Get Even Murkier at Bloomberg
04:00PM  What we know about the former Valeant employee who just got arrested on fraud charges
04:00PM  STOCKS RISE: Here's what you need to know
03:06PM  Valeant and Philidor Execs Were Building 'Nest Eggs' from Valeant Stakeholders' Money, Bharara Says
02:02PM  Valeant (VRX) 'Ripped Off Pretty Hard' by Own People
01:53PM  [$$] Two executives charged over illegal kickback scheme at Valeant at Financial Times
01:30PM  Fraud Charges for Former Valeant, Philidor Executives
01:28PM  The market is ignoring a massive elephant in the room at Valeant
01:04PM  First criminal charges in Valeant investigation nab former exec, Philidor CEO at MarketWatch
01:04PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Financials
01:04PM  Ex-Valeant Execs Tied to Philidor Charged in Fraud at Investopedia
11:54AM  Two men charged with kickback scheme at Valeant Reuters
11:16AM  Federal prosecutors to charge Valeant, Philidor execs with fraud and kickback scheme: WSJ at MarketWatch
11:09AM  Valeant: Why Fraud Charges are Bad, Bad, News at Barrons.com
11:08AM  Valeant confirms criminal charges filed against Valeant, Philidor executives at MarketWatch
11:07AM  Billionaire James Chanos: Valeant is Worse than Enron at Investopedia
10:46AM  Valeant Comments On Issued Philidor Criminal Charges PR Newswire
10:46AM  Valeant Comments On Issued Philidor Criminal Charges CNW Group
10:07AM  Valeant and Philidor Execs Face Fraud Charges
10:03AM  Two executives charged in big Valeant kickback scheme at CNBC
09:41AM  Valeant tumbles after the CEO of its secret pharmacy was arrested
09:40AM  Valeant, Philidor Executives Charged With Fraud by U.S. at Bloomberg
09:19AM  The CEO of Valeant's secret pharmacy has been charged with 'engaging in a multi-million dollar fraud and kickback scheme'
Nov-16-16 02:15PM  Mizuho Defends Mallinckrodt Against Citron, Says Buy The Dip
12:25PM  Andrew Left: Dump Mallinckrodt
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Xifaxan for the treatment of irritable bowel syndrome with diarrhea; Wellbutrin XL for major depressive disorder in adults; Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Clindagel, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Glumetza to improve glycemic control in adults with type 2 diabetes mellitus; PROVENGE for the treatment of prostate cancer; and Jublia for onychomycosis of the toenails. It also provides Nitropress for the immediate reduction of blood pressure of patients in hypertensive crises; Isuprel for heart related treatments; Xenazine for chorea; Uceris to get ulcerative colitis under control; Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; Biotrue for healthy contact lens wear; and ReNu Multiplus to lubricate and rewet soft contact lenses. In addition, the company offers Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; various ophthalmic surgical products; SofLens daily disposable contact lenses; Biotrue ONEday lens; Bausch + Lomb Ultra, a contact lens PureVision, a contact lens; and medical device systems for aesthetic applications. Further, it provides Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Metronidazole to treat bacterial infections; and Latanoprost for the treatment of glaucoma. Valeant Pharmaceuticals International, Inc. was founded in 1983 and is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KARABELAS ARGERIS NDirectorAug 11Buy24.654,00098,60020,726Aug 12 04:37 PM
Ross Thomas W. Sr.DirectorJun 13Buy24.404,00097,60021,882Jun 27 03:40 PM
PAPA JOSEPH CCHAIRMAN & CEOJun 10Buy24.48202,0004,944,9602,442,199Jun 13 06:47 AM
LYB LyondellBasell Industries N.V. daily Stock Chart
LYB [NYSE]
LyondellBasell Industries N.V.
IndexS&P 500 P/E9.91 EPS (ttm)8.94 Insider Own18.58% Shs Outstand416.85M Perf Week3.53%
Market Cap36.93B Forward P/E8.94 EPS next Y9.91 Insider Trans0.00% Shs Float328.43M Perf Month14.26%
Income3.87B PEG- EPS next Q2.40 Inst Own73.90% Short Float2.81% Perf Quarter12.59%
Sales28.51B P/S1.30 EPS this Y20.00% Inst Trans-4.64% Short Ratio2.75 Perf Half Y8.71%
Book/sh14.73 P/B6.01 EPS next Y4.63% ROA16.60% Target Price89.60 Perf Year-5.18%
Cash/sh4.39 P/C20.18 EPS next 5Y-1.75% ROE61.20% 52W Range67.03 - 93.74 Perf YTD5.11%
Dividend3.40 P/FCF24.65 EPS past 5Y-11.60% ROI30.00% 52W High-5.49% Beta1.21
Dividend %3.84% Quick Ratio1.30 Sales past 5Y-4.50% Gross Margin20.80% 52W Low32.18% ATR2.20
Employees13000 Current Ratio2.20 Sales Q/Q-11.60% Oper. Margin17.90% RSI (14)62.49 Volatility3.28% 2.40%
OptionableYes Debt/Eq1.49 EPS Q/Q-10.20% Profit Margin13.60% Rel Volume1.21 Prev Close89.14
ShortableYes LT Debt/Eq1.39 EarningsNov 01 BMO Payout36.40% Avg Volume3.35M Price88.60
Recom2.60 SMA206.04% SMA509.37% SMA20011.00% Volume4,046,725 Change-0.61%
Oct-14-16Initiated Tudor Pickering Buy
Sep-13-16Reiterated Deutsche Bank Hold $80 → $83
Jun-27-16Downgrade RBC Capital Mkts Outperform → Sector Perform $100 → $84
Jun-23-16Downgrade JP Morgan Overweight → Neutral $100 → $80
Jun-13-16Downgrade Cowen Outperform → Market Perform $105 → $87
Apr-27-16Downgrade Nomura Buy → Neutral
Apr-05-16Downgrade Atlantic Equities Neutral → Underweight
Feb-03-16Downgrade RBC Capital Mkts Top Pick → Outperform $105 → $95
Jan-11-16Downgrade Credit Agricole Outperform → Underperform
Nov-25-15Reiterated Cowen Outperform $98 → $105
Oct-12-15Downgrade Macquarie Outperform → Neutral
Sep-17-15Reiterated Deutsche Bank Hold $100 → $95
Sep-11-15Initiated Bernstein Outperform $110
Sep-01-15Reiterated Cowen Outperform $115 → $98
May-08-15Initiated Standpoint Research Buy
Apr-28-15Reiterated RBC Capital Mkts Top Pick $111 → $123
Apr-27-15Reiterated Jefferies Hold $85 → $99
Apr-27-15Reiterated Deutsche Bank Hold $96 → $105
Apr-27-15Reiterated Barclays Overweight $105 → $115
Mar-13-15Initiated Argus Hold
Dec-03-16 03:03PM  The Best Plastic Stocks to Buy Today at Motley Fool
Nov-29-16 04:13AM  2 chemical stocks to buy and 2 to sell at MarketWatch
02:25AM  LyondellBasell Industries NV (LYB): Are Hedge Funds Right About This Stock? at Insider Monkey
Nov-28-16 01:34PM  Positives and Negatives of LyondellBasells 3Q16 Earnings
07:51AM  4 Blue Chip Stocks to Buy as Trump Rally Rages On
Nov-21-16 01:04PM  LyondellBasell Declares 4Q Dividend of $0.85
Nov-18-16 06:45AM  LyondellBasell Board Authorizes Interim Dividend PR Newswire
Nov-17-16 12:00PM  LyondellBasell to Address Citi's Basic Materials Conference PR Newswire
11:19AM  Polish Basell Orlen declares force majeure on some products
Nov-16-16 11:13AM  Andreas Halvorsen's Top 3 New Holdings
Nov-14-16 01:50PM  Two Chemicals Stocks Expected To Surge Under Trump Administration at Forbes
Nov-08-16 08:04AM  Lower Oil Prices Affect LYBs Refining Segments 3Q16 Earnings
Nov-07-16 04:06PM  A Quick Look at a Few Chemical Companies in 2016
11:04AM  What Do Analysts Think of LyondellBasell after Its 3Q16 Earnings?
10:04AM  How LYBs Intermediates & Derivatives Segment Performed in 3Q16
08:06AM  Why LYBs Olefins & Polyolefins EAI Segment Saw Higher Earnings
Nov-05-16 01:04PM  LYONDELLBASELL INDUSTRIES N.V. Financials
Nov-04-16 05:04PM  How LYBs Olefins & Polyolefins Americas Segment Did in 3Q16
03:04PM  Why Did LyondellBasells 3Q16 Earnings Miss Estimates?
01:13PM  Planned Maintenance Continues to Weigh Heavily on LyondellBasell
Nov-03-16 12:15PM  ETFs with exposure to LyondellBasell Industries NV : November 3, 2016
Nov-02-16 06:00PM  LyondellBasell to Address Morgan Stanley Global Chemicals and Agriculture Conference PR Newswire
09:44AM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: Q3, 2016 By the Numbers : November 2, 2016
08:33AM  LyondellBasell Industries NV breached its 50 day moving average in a Bearish Manner : LYB-US : November 2, 2016
Nov-01-16 06:40PM  Edited Transcript of LYB earnings conference call or presentation 1-Nov-16 3:00pm GMT
11:04AM  Why Did DuPonts Electronics and Communications Segment Revenue Decline in 3Q16?
11:02AM  [$$] LyondellBasell Results Hurt by Operating Disruptions at The Wall Street Journal
10:12AM  LyondellBasell (LYB) Beats on Q3 Earnings and Revenues
10:04AM  DuPonts Protection Solutions Revenue in 3Q16 Remained Flat amid Higher Volumes
08:39AM  LyondellBasell (LYB) Q3 Earnings and Sales Beat Estimates
08:02AM  Will LyondellBasell (LYB) Stock Be Hurt by Q3 Miss?
07:58AM  LyondellBasell beats Street 3Q forecasts
07:07AM  Q3 2016 LyondellBasell Industries NV Earnings Release - Before Market Open
06:47AM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
06:45AM  LyondellBasell Reports Third-Quarter 2016 Earnings PR Newswire
Oct-31-16 11:46AM  [$$] Just how LBI went bust is subject to legal controversy at Financial Times
11:25AM  What to Watch When LyondellBasell (LYB) Reports Q3 Earnings
11:03AM  3 Reasons Value Stock Investors Will Love LyondellBasell (LYB)
09:47AM  Why Earnings Season Could Be Great for LyondellBasell (LYB)
08:53AM  Chemical Stocks Q3 Earnings Slated on Nov 1: LYB, ECL, TSE
Oct-28-16 08:16AM  CVR Partners (UAN) Q3 Loss Wider than Expected, Sales Lag
07:37AM  LyondellBasell (LYB) Q3 Earnings: A Beat in the Cards?
Oct-27-16 11:04AM  Why Is LyondellBasell Trading at a Discount to Its Peers?
10:05AM  Why Wall Street Analysts Are Cautious on LyondellBasell
09:30AM  Zacks.com featured highlights: LyondellBasell Industries N.V., Citrix Systems, Boston Scientific, Broadcom and ConAgra Foods
08:05AM  Why Do Analysts Expect Lower 3Q16 Margins for LyondellBasell?
Oct-26-16 06:04PM  Can LyondellBasell Beat 3Q16 Estimates amid Its Maintenance Woes?
04:27PM  Will LyondellBasells Stock Continue to Recover in 4Q16?
09:47AM  What's behind calls in LyondellBasell
08:05AM  5 Top ROE Picks as Q3 Earnings Bells Chime
Oct-21-16 05:48PM  [$$] Len Blavatnik Defends Boom-Era Merger of LyondellBasell at The Wall Street Journal
03:48PM  Blavatnik Says $22 Billion LyondellBasell Merger Was Worth It
Oct-19-16 03:46PM  Lyondell Hearing Raises Ghosts Of Ill-Fated Debt-Laden Merger at Forbes
Oct-17-16 05:54PM  [$$] Trial Begins in Lyondell Clawback Lawsuit at The Wall Street Journal
07:30AM  LyondellBasell to Discuss Third-Quarter Results on Tuesday, November 1, 2016 PR Newswire
Oct-14-16 06:03AM  Coverage initiated on LyondellBasell by Tudor Pickering
Oct-13-16 04:02PM  Be Aware of These Low P/S Stocks
Oct-12-16 11:17AM  LyondellBasell Industries NV : LYB-US: Dividend Analysis : August 16th, 2016 (record date) : By the numbers : October 12, 2016
Oct-11-16 09:15AM  Here's Why These 2 Top Chemical Stocks Are Strong Buys Right Now
Oct-07-16 08:42AM  Is LyondellBasell Industries (LYB) Stock a Solid Choice Right Now?
Oct-06-16 09:30AM  Zacks.com featured highlights: Cooper Tire & Rubber, Ultra Petroleum, LyondellBasell Industries N.V., Apogee Enterprises and Summit Materials
08:51AM  3 Reasons Why LyondellBasell (LYB) is a Great Value Stock
Oct-05-16 08:44AM  5 Efficient Stocks That Promise Impressive Returns
Sep-26-16 05:52PM  Jefferies Announces an Upward Revision of LyondellBasells Price Target
Sep-22-16 05:36PM  LyondellBasell (LYB) Stock Price Target Raised at Jefferies
Sep-21-16 11:36AM  LyondellBasell Industries NV Value Analysis (NYSE:LYB) : September 21, 2016
Sep-20-16 08:17AM  LyondellBasell Industries NV breached its 50 day moving average in a Bullish Manner : LYB-US : September 20, 2016
Sep-19-16 06:22PM  Jeff Auxier Buys Biogen, LyondellBasell and Union Pacific
Sep-15-16 07:16AM  Several bullish trades in LyondellBasell
Sep-13-16 12:28AM  PRESS DIGEST- New York Times business news - Sept 13 Reuters
Sep-12-16 07:20AM  LyondellBasell (LYB) to Build HDPE Plant at La Porte Complex
Sep-09-16 08:30AM  LyondellBasell Will Build High Density Polyethylene Plant at La Porte, Texas, Complex PR Newswire
Sep-04-16 03:00PM  Top 5 Petrochemical Stocks of 2016 (ALB, CBT) at Investopedia
Aug-31-16 07:00AM  LyondellBasell to Address Credit Suisse Basic Materials Conference PR Newswire
Aug-29-16 07:00AM  LyondellBasell to Address RBC Capital Markets' Industrial Conference PR Newswire
Aug-26-16 08:09AM  How Will LyondellBasell (LYB) Stock React to Potential Houston Refinery Sale?
Aug-23-16 04:15PM  CF Industries shares rise nearly 5 pct on UBS upgrade at CNBC
Aug-19-16 08:10AM  LyondellBasell Poised on Expansion Actions, Headwinds Remain
Aug-18-16 02:11PM  Argus Believes Oil Price Volatility A Headwind For LyondellBasell
Aug-16-16 10:10AM  Stock Market News for August 16, 2016
08:10AM  LyondellBasell Industries NV breached its 50 day moving average in a Bullish Manner : LYB-US : August 16, 2016
Aug-15-16 10:34AM  ETFs with exposure to LyondellBasell Industries NV : August 15, 2016
10:10AM  Stock Market News for August 15, 2016
Aug-11-16 03:33PM  Why Did Albemarles 2Q16 Revenue Miss Analyst Expectations?
11:28AM  Billionaire Ray Dalio Loads Up On Lyondell, Mining Stocks in Q2 at Insider Monkey
09:30AM  Zacks Industry Outlook Highlights: Eastman Chemical, LyondellBasell Industries, Methanex, CF Industries Holdings and Mosaic
Aug-10-16 11:04AM  Why Did LyondellBasells Technology Segments Revenue Rise in Q2?
09:04AM  Why LYBs Refining Segment Posted an Earnings Loss in Q2
Aug-09-16 03:47PM  Chemical Industry Stock Outlook - Aug 2016
11:05AM  LYBs Intermediates and Derivatives Revenue Also Fell in 2Q16
09:05AM  Why LYBs Olefins and Polyolefins EAI Revenue Fell in 2Q16
Aug-08-16 11:06AM  Why LYBs Olefins & Polyolefins Americas Revenue Fell in 2Q16
09:06AM  Reviewing LyondellBasells Valuations after Its 2Q16 Earnings
Aug-05-16 01:20PM  Why Did LyondellBasells 2Q16 Revenues Miss Analysts Estimates?
01:20PM  LyondellBasells 2Q16 Earnings Missed Analysts Estimates
Aug-04-16 03:03PM  ETFs with exposure to LyondellBasell Industries NV : August 4, 2016
Aug-03-16 11:34AM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016
Aug-02-16 11:07AM  Dow Chemicals 2Q16 Earnings Proved Analysts Estimates Wrong
Aug-01-16 12:51PM  LyondellBasell Industries NV breached its 50 day moving average in a Bearish Manner : LYB-US : August 1, 2016
10:45AM  Five Stocks in Spotlight Amid Earnings, M&A News at Insider Monkey
LyondellBasell Industries N.V. operates as a manufacturer of chemicals and polymers, refiner of crude oil, producer of gasoline blending components, and developer and licensor of technologies for production of polymers. The company operates in five segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Refining; and Technology. It produces and markets olefins, including ethylene, propylene, and butadiene; polyolefins, which consist of high density polyethylene, low density polyethylene, linear low density polyethylene, and polypropylene (PP); specialty polyolefins comprising PP compounds, catalloy process resins, and polybutene-1 resins; and aromatics, which include benzene. The company also produces and markets propylene oxide (PO); PO co-products, such as styrene monomers and tertiary butyl alcohol; PO derivatives consisting of propylene glycol, propylene glycol ethers, and butanediol; acetyls, including methanol, acetic acid, and vinyl acetate monomers; and ethylene derivatives, such as ethylene oxide, ethylene glycol, ethylene glycol ethers, and ethanol. In addition, it refines gasoline and components, ultra low sulfur diesel, jet fuel, lube oils, and aromatics. Further, the company develops and licenses chemical, polyolefin, and other process technologies, as well as provides associated engineering and other services; and develops, manufactures, and sells polyolefin catalysts. LyondellBasell Industries N.V. was founded in 2005 and is based in London, United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bindra Jagjeet S.DirectorAug 30Sale80.013,750300,0208,876Sep 01 09:17 AM
Covezzi MassimoSVP Research & DevelopmentApr 26Sale89.147,551673,1119,702Apr 26 04:28 PM
Vasnetsov SergeySVP Strategic PlanningApr 26Sale89.893,127281,0764,733Apr 26 04:28 PM
AI INTERNATIONAL CHEMICALS S.A10% OwnerMar 09Sale82.531,100,00090,786,41077,354Mar 10 04:38 PM
AI INTERNATIONAL CHEMICALS S.A10% OwnerMar 08Sale82.041,000,00082,042,77779,646Mar 10 04:38 PM
TMO Thermo Fisher Scientific Inc. daily Stock Chart
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E28.22 EPS (ttm)5.01 Insider Own0.10% Shs Outstand394.70M Perf Week0.76%
Market Cap55.80B Forward P/E15.23 EPS next Y9.28 Insider Trans-38.50% Shs Float393.85M Perf Month-3.22%
Income2.00B PEG2.51 EPS next Q2.40 Inst Own88.40% Short Float1.09% Perf Quarter-6.27%
Sales17.97B P/S3.10 EPS this Y4.60% Inst Trans-0.69% Short Ratio2.22 Perf Half Y-7.22%
Book/sh54.87 P/B2.58 EPS next Y12.43% ROA- Target Price174.17 Perf Year3.58%
Cash/sh5.03 P/C28.12 EPS next 5Y11.25% ROE- 52W Range119.38 - 160.52 Perf YTD-0.02%
Dividend0.60 P/FCF- EPS past 5Y15.00% ROI7.00% 52W High-11.92% Beta1.18
Dividend %0.42% Quick Ratio1.10 Sales past 5Y10.30% Gross Margin45.60% 52W Low18.43% ATR3.02
Employees52000 Current Ratio1.60 Sales Q/Q8.90% Oper. Margin- RSI (14)36.59 Volatility1.98% 2.10%
OptionableYes Debt/Eq0.87 EPS Q/Q0.40% Profit Margin- Rel Volume1.50 Prev Close141.91
ShortableYes LT Debt/Eq0.78 EarningsOct 27 BMO Payout- Avg Volume1.94M Price141.38
Recom1.70 SMA20-3.48% SMA50-6.08% SMA200-4.78% Volume2,919,158 Change-0.37%
Nov-10-16Resumed Leerink Partners Outperform
Sep-22-16Resumed JP Morgan Overweight $180
Sep-09-16Downgrade Cleveland Research Buy → Neutral
May-27-16Reiterated Mizuho Buy $166 → $170
May-19-16Reiterated Mizuho Buy $163 → $166
May-03-16Reiterated Mizuho Buy $160 → $163
Apr-29-16Downgrade Jefferies Buy → Hold
Apr-04-16Reiterated Mizuho Buy $150 → $160
Mar-02-16Reiterated Topeka Capital Markets Buy $145 → $155
Jan-11-16Reiterated Stifel Buy $150 → $158
Jan-07-16Initiated Deutsche Bank Buy $160
Oct-06-15Initiated Argus Buy $145
Jul-23-15Reiterated Mizuho Buy $150 → $160
May-21-15Reiterated Barclays Overweight $160 → $165
Mar-10-15Initiated UBS Buy $160
Jan-21-15Reiterated Robert W. Baird Outperform $142 → $144
Aug-12-14Initiated Stifel Buy $150
Jan-30-14Reiterated Mizuho Buy $130 → $140
Jan-30-14Reiterated ISI Group Buy $121.50 → $130
Jan-10-14Reiterated UBS Buy $107 → $127
Dec-03-16 07:43PM  5 Capital Goods Stocks Hedge Funds Were Dumping in Q3 at Insider Monkey
Dec-02-16 02:46PM  MedTech Sails Through Macro Woes: Stocks in Focus
08:05AM  Boston Scientific Completes Its Acquisition of EndoChoice
Dec-01-16 10:05AM  Baxter Makes Significant Advancements in Hemodialysis Treatments
08:05AM  How Baxter Continues to Contribute to Patient Care
Nov-30-16 05:02PM  A Growth Stock in the Land of Value Stocks?
10:48AM  What Are Analysts Recommendations for Thermo Fisher Scientific?
10:48AM  TMO Creates Shareholder Value through Strong Capital Allocation
10:48AM  How Is Thermo Fisher Scientifics FEI Integration Process Going?
10:48AM  How Is Thermo Fisher Scientific Accelerating Growth?
10:48AM  How Has Thermo Fisher Scientifics Stock Performed Recently?
Nov-28-16 02:57PM  Battle of Bulls and Bears Lies Ahead for Thermo Fisher
09:30AM  Zacks.com featured highlights: First American Financial, AngioDynamics, Microsemi, Thermo Fisher Scientific and F5 Networks
07:41AM  Is Thermo Fisher Scientific Inc. (TMO) a Good Stock to Invest in? at Insider Monkey
Nov-25-16 08:18AM  5 GARP Stocks to Benefit from Trump Induced Rebound
Nov-23-16 12:21PM  Eli Lilly & Juno Therapeutics plummet after failed drug t...
Nov-21-16 11:04AM  Exploring the Nuances of Strykers Cost Transformation for Growth
10:04AM  How Is Stryker Moving Forward with International Growth?
08:04AM  How Are Strykers Core Strategies Working Toward Its Growth?
Nov-18-16 04:37PM  What Are Analysts Latest Recommendations for Stryker?
Nov-15-16 09:31AM  Thermo Fisher Scientific Inc. (TMO), HCA Holdings Inc (HCA) & Two More: Should You Follow Cryder Capital Into Its Top Picks? at Insider Monkey
Nov-13-16 04:45PM  Thermo Fisher shares could rise 30 pct over the next 2 years -Barron's
Nov-12-16 12:01AM  [$$] Thermo Fisher Has 30% Upside at Barrons.com
Nov-11-16 06:04PM  What Were Becton Dickinsons 4Q16 Growth Drivers?
Nov-10-16 04:30PM  Thermo Fisher Scientific Declares Quarterly Dividend Business Wire
01:04PM  THERMO FISHER SCIENTIFIC INC. Financials
09:30AM  The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, Arch Capital Group, IPG Photonics, AngioDynamics and Express Scripts Holding
Nov-09-16 09:00AM  5 GARP Stocks to Buy Now
07:28AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : November 9, 2016
Nov-08-16 08:30AM  Thermo Fisher Scientific and Hamilton Storage Partner to Simplify Sample Storage Business Wire
Nov-05-16 12:13PM  The Unsung Heroes of CAR-T at Motley Fool
Nov-04-16 12:12PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 10-Q, Quarterly Report
10:00AM  How to Position Before the Presidential Election
08:15AM  Blog Coverage VWR Corporation Announces Two Acquisitions Accesswire
Nov-02-16 08:06AM  Thermo Fisher Scientific Updated Its 2016 Guidance
Nov-01-16 11:06AM  Analyzing Thermo Fisher Scientifics Recent Stock Performance
10:07AM  Highlights from Thermo Fisher Scientifics 3Q16 Earnings
08:46AM  5 Top Stocks with Imposing Earnings Growth
08:07AM  Analysts Recommendations for Thermo Fisher Scientific
Oct-31-16 02:13PM  ETFs with exposure to Thermo Fisher Scientific, Inc. : October 31, 2016
Oct-28-16 09:29AM  Thermo Fisher Scientific, Inc. :TMO-US: Earnings Analysis: Q3, 2016 By the Numbers : October 28, 2016
09:21AM  7 Dividend Stocks That Promise Stability and Growth
08:30AM  Thermo Fisher Scientific to Present at Bairds 2016 Industrial Conference on November 8, 2016 Business Wire
Oct-27-16 04:51PM  Edited Transcript of TMO earnings conference call or presentation 27-Oct-16 12:30pm GMT
11:30AM  [$$] Thermo Fisher Scientific Lifts Outlook at The Wall Street Journal
09:33AM  Thermo Fisher (TMO) Tops Q3 Earnings, Raises '16 Outlook
08:10AM  Thermo Fisher Scientific (TMO): Tops Q3 Earnings and Revenue
07:32AM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
07:07AM  Q3 2016 Thermo Fisher Scientific Inc Earnings Release - Before Market Open
06:08AM  Thermo Fisher beats Street 3Q forecasts
06:00AM  Thermo Fisher raises 2016 revenue, earnings forecasts
06:00AM  Thermo Fisher Scientific Reports Third Quarter 2016 Results Business Wire
Oct-26-16 10:00AM  Can Thermo Fisher (TMO) Pull a Surprise in Q3 Earnings?
09:39AM  Analysts Recommendations ahead of BDXs Fiscal 4Q16 Earnings
09:30AM  Zacks.com featured highlights: AngioDynamics, Luxoft Holding, Boston Scientific, Popeyes Louisiana Kitchen and Thermo Fisher Scientific
08:20AM  Medical Instrument Earnings Slated on Oct 27: TMO, ABMD, TFX
Oct-25-16 09:42AM  5 GARP Stocks Well Positioned to Provide Impressive Yields
Oct-21-16 12:46PM  Time Out's CEO says its $1.9 million YPlan acquisition is all about selling happiness
08:41AM  Clinton's Odds of Winning Presidency High: Top 5 Picks
Oct-20-16 08:30AM  Thermo Fisher Scientific Partners with Boys & Girls Clubs of America to Bring STEM Education to the Next Generation of Employees and Leaders Business Wire
06:00AM  'Mad Money' Lightning Round: Stick With AMN Healthcare
Oct-19-16 07:02PM  Cramer: Move over H&R Block, this tax play is taking the world by storm at CNBC
12:56PM  What IBM's Genomic Partnership With Quest Says About Thermo Fisher, Diagnostics Peers
Oct-18-16 09:30AM  Zacks.com featured highlights: Lennox International, Spectrum Brands Holdings, ULTA Salon, Cosmetics & Fragrance, ONE Gas and Thermo Fisher Scientific
Oct-17-16 04:30PM  Thermo Fisher Scientific Joins Cancer Moonshot Effort Business Wire
12:04PM  Analyzing Abbott Laboratories 3Q16 Revenue Estimates
07:30AM  White House To Announce Big Push For Cancer Blood Tests at Forbes
07:07AM  Q3 Earnings May Not be as Dreary: 5 Solid Picks
Oct-15-16 08:12AM  Thermo Fisher's Handheld Drug Analyzer, Other Products Make It a Good Investment
Oct-14-16 12:31PM  The Zacks Analyst Blog Highlights: Caterpillar, Microsoft, Thermo Fisher, Alcoa and PNC Financial
Oct-13-16 01:06PM  New Research Reports for Microsoft, Caterpillar & Thermo Fisher Zacks
12:24PM  BofA: Expect upside to Merck estimates
08:30AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bearish Manner : TMO-US : October 13, 2016
07:49AM  Thermo Fisher: Buyout Synergies on Track, Grows Globally
Oct-12-16 04:30PM  3 Warning Signs from Illumina, Inc.'s Q3 Preview at Motley Fool
Oct-05-16 04:51PM  Broadcom, Thermo Fisher, Stryker Top Thursday Investing Action Plan
12:38PM  Thermo Fisher Scientific, Inc. : TMO-US: Dividend Analysis : September 15th, 2016 (record date) : By the numbers : October 5, 2016
08:04AM  Analysts Strong Buy Recommendation for Thermo Fisher Scientific
Oct-04-16 11:04AM  Thermo Fisher Scientifics Latest Valuation
10:05AM  TMOs Shareholder Return Strategy: Latest Dividend Payment
08:05AM  TMO Focused on Strengthening Its Emerging Market Presence
Oct-03-16 04:30PM  Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, October 27, 2016 Business Wire
12:30PM  Why Cleveland Research Heats Up the Market
11:06AM  Thermo Fisher Scientific Completed the FEI Acquisition
10:06AM  A Look at Thermo Fisher Scientifics Recent Product Approvals
08:30AM  Thermo Fisher Scientific Expands Global Footprint to Support Cell and Gene Therapy Clinical Trials in Japan Business Wire
08:07AM  Thermo Fisher Scientifics Recent Stock Performance
Sep-30-16 04:40PM  Medical Device ETF Near Highs As Products, Equipment Groups Outperform
Sep-26-16 12:55PM  Bullish and Bearish Reversals for the Week
Sep-23-16 04:25PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Sep-20-16 06:14PM  The Cooper Companies Set to Join the S&P 500; Northwestern and NuVasive to Join S&P MidCap 400; SPS Commerce and Fox Factory to Join S&P SmallCap 600 PR Newswire
07:57AM  Thermo Fisher Adds FEI Co., Inorganic Expansion Continues
Sep-19-16 08:01PM  Thermo Fisher Scientific Completes Acquisition of FEI Company Business Wire
04:17PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an
Sep-15-16 04:10PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:32AM  Thermo Fisher Scientific Inc. -- Moody's assigns Baa2 to Thermo Fisher's USD bonds; outlook stable at Moody's
Sep-14-16 04:57PM  Thermo Fisher Scientific Prices Offering of Senior Notes Business Wire
Sep-12-16 06:27AM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an
Sep-09-16 09:35AM  Thermo Fisher downgraded by Cleveland Research
Sep-08-16 04:19PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company's Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company's Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASPER MARC NChief Executive OfficerSep 02Option Exercise54.9728,7971,582,971307,444Sep 06 04:52 PM
CASPER MARC NChief Executive OfficerSep 02Sale151.0128,7974,348,635278,647Sep 06 04:52 PM
CASPER MARC NChief Executive OfficerSep 01Option Exercise54.9730,0001,649,100308,647Sep 02 05:32 PM
CASPER MARC NChief Executive OfficerSep 01Sale151.1730,0004,535,076278,647Sep 02 05:32 PM
Shine Daniel PSenior Vice PresidentAug 29Sale152.281,699258,72417,437Aug 31 05:00 PM
Loewald Thomas WSenior Vice PresidentAug 29Sale152.283,256495,82435,814Aug 31 04:58 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Aug 29Sale152.282,270345,67627,384Aug 31 04:56 PM
Shine Daniel PSenior Vice PresidentAug 26Sale151.7847672,24719,136Aug 30 05:20 PM
Loewald Thomas WSenior Vice PresidentAug 26Sale151.92913138,70339,070Aug 30 05:17 PM
CASPER MARC NChief Executive OfficerAug 15Sale155.9625,0003,899,031295,998Aug 17 04:54 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Aug 10Sale156.005,023783,58831,914Aug 11 04:46 PM
HARRIS C MARTINDirectorAug 05Sale157.3339061,3594,648Aug 08 04:53 PM
Loewald Thomas WSenior Vice PresidentJul 13Option Exercise73.248,025587,75152,194Jul 14 04:35 PM
Loewald Thomas WSenior Vice PresidentJul 13Sale155.008,0251,243,87544,169Jul 14 04:35 PM
CASPER MARC NChief Executive OfficerJul 05Option Exercise54.9720,0001,099,400340,998Jul 07 04:42 PM
CASPER MARC NChief Executive OfficerJul 05Sale147.6920,0002,953,804320,998Jul 07 04:42 PM
CASPER MARC NChief Executive OfficerJul 01Option Exercise54.9730,0001,649,100350,998Jul 06 04:42 PM
CASPER MARC NChief Executive OfficerJul 01Sale148.8530,0004,465,638320,998Jul 06 04:42 PM
Shine Daniel PSenior Vice PresidentJun 15Option Exercise54.976,900379,29328,779Jun 16 05:00 PM
Shine Daniel PSenior Vice PresidentJun 15Sale148.316,9001,023,35621,879Jun 16 05:00 PM
WILVER PETER MExec. VP & Chief Admin OfficerJun 10Option Exercise54.9768,2003,748,954138,777Jun 14 04:47 PM
WILVER PETER MExec. VP & Chief Admin OfficerJun 10Sale152.3868,20010,392,63370,577Jun 14 04:47 PM
MANZI JIM PDirectorJun 03Sale153.001,137173,96138,733Jun 06 04:41 PM
Loewald Thomas WSenior Vice PresidentJun 02Option Exercise73.2415,0001,098,60059,169Jun 06 04:39 PM
Loewald Thomas WSenior Vice PresidentJun 02Sale152.8415,0002,292,60044,169Jun 06 04:39 PM
Williamson StephenSr. VP and CFOMay 25Option Exercise54.973,740205,58833,821May 26 04:38 PM
Williamson StephenSr. VP and CFOMay 24Option Exercise54.978,660476,04038,741May 26 04:38 PM
Williamson StephenSr. VP and CFOMay 24Sale150.298,6601,301,48330,081May 26 04:38 PM
HORNSTRA PETER EVP & Chief Accounting OfficerMay 16Option Exercise68.386,357434,69425,671May 17 11:39 AM
HORNSTRA PETER EVP & Chief Accounting OfficerMay 16Sale150.007,8111,171,65017,860May 17 11:39 AM
Shine Daniel PSenior Vice PresidentApr 26Option Exercise54.975,000274,85027,892Apr 27 04:09 PM
Shine Daniel PSenior Vice PresidentApr 26Sale146.006,013877,89821,879Apr 27 04:09 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Apr 05Option Exercise73.2410,000732,40046,937Apr 07 04:28 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Apr 05Sale141.8610,0001,418,58036,937Apr 07 04:28 PM
Durbin Patrick MSenior Vice PresidentApr 04Option Exercise64.3911,250724,37944,348Apr 06 04:21 PM
Durbin Patrick MSenior Vice PresidentApr 04Sale142.1816,2502,310,42528,098Apr 06 04:21 PM
Williamson StephenSr. VP and CFOMar 22Option Exercise51.634,592237,07830,081Mar 23 04:36 PM
Williamson StephenSr. VP and CFOMar 21Option Exercise51.7510,708554,09536,197Mar 23 04:36 PM
Williamson StephenSr. VP and CFOMar 21Sale139.5010,7081,493,76625,489Mar 23 04:36 PM
CASPER MARC NChief Executive OfficerMar 14Sale139.2830,0004,178,296320,998Mar 16 05:40 PM
Malus Alan JExecutive Vice PresidentMar 10Option Exercise126.3925,9253,276,78873,211Mar 14 04:47 PM
Malus Alan JExecutive Vice PresidentMar 10Sale139.0525,9253,604,80947,286Mar 14 04:47 PM
Malus Alan JExecutive Vice PresidentMar 09Option Exercise73.2411,525844,09162,732Mar 11 04:07 PM
Malus Alan JExecutive Vice PresidentMar 09Sale138.5015,4462,139,29047,286Mar 11 04:07 PM
SPERLING SCOTT MDirectorMar 03Option Exercise36.8720,000737,40085,790Mar 07 04:31 PM
Loewald Thomas WSenior Vice PresidentMar 03Option Exercise49.493,625179,40147,794Mar 04 07:15 PM
Loewald Thomas WSenior Vice PresidentMar 03Sale137.283,625497,64044,169Mar 04 07:15 PM
SPERLING SCOTT MDirectorMar 03Sale137.905,350737,74580,440Mar 07 04:31 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Mar 01Sale135.002,951398,38536,937Mar 02 05:12 PM
Shine Daniel PSenior Vice PresidentFeb 29Sale130.2461479,96722,892Mar 02 04:50 PM
Shine Daniel PSenior Vice PresidentFeb 26Option Exercise54.975,000274,85030,089Mar 01 05:30 PM
Shine Daniel PSenior Vice PresidentFeb 26Sale131.006,180809,58023,909Mar 01 05:30 PM
Malus Alan JExecutive Vice PresidentFeb 01Option Exercise59.04103,4006,105,022149,221Feb 02 04:41 PM
Malus Alan JExecutive Vice PresidentFeb 01Sale130.24103,40013,467,21145,821Feb 02 04:41 PM
Loewald Thomas WSenior Vice PresidentDec 14Option Exercise54.977,013385,50544,451Dec 16 03:47 PM
Loewald Thomas WSenior Vice PresidentDec 14Sale134.1813,0131,746,08431,438Dec 16 03:47 PM
Parrett William GDirectorDec 11Buy134.161,000134,16014,636Dec 15 03:36 PM
Malus Alan JExecutive Vice PresidentDec 07Option Exercise49.4982,3004,073,027128,121Dec 08 05:07 PM
Malus Alan JExecutive Vice PresidentDec 07Sale135.4982,30011,150,96345,821Dec 08 05:07 PM
CRM salesforce.com, inc. daily Stock Chart
CRM [NYSE]
salesforce.com, inc.
IndexS&P 500 P/E240.82 EPS (ttm)0.29 Insider Own0.10% Shs Outstand697.21M Perf Week-2.92%
Market Cap49.36B Forward P/E55.36 EPS next Y1.28 Insider Trans-76.47% Shs Float658.31M Perf Month-4.50%
Income205.60M PEG8.04 EPS next Q0.25 Inst Own84.50% Short Float2.83% Perf Quarter-6.13%
Sales7.91B P/S6.24 EPS this Y83.00% Inst Trans-2.30% Short Ratio2.16 Perf Half Y-14.84%
Book/sh9.86 P/B7.18 EPS next Y30.78% ROA1.50% Target Price94.40 Perf Year-13.81%
Cash/sh1.72 P/C41.11 EPS next 5Y29.94% ROE3.50% 52W Range52.60 - 84.48 Perf YTD-9.69%
Dividend- P/FCF32.32 EPS past 5Y-21.10% ROI0.00% 52W High-16.19% Beta1.48
Dividend %- Quick Ratio0.60 Sales past 5Y32.10% Gross Margin74.10% 52W Low34.60% ATR2.08
Employees19000 Current Ratio0.60 Sales Q/Q25.30% Oper. Margin1.30% RSI (14)43.20 Volatility3.41% 2.70%
OptionableYes Debt/Eq0.37 EPS Q/Q-42.60% Profit Margin2.60% Rel Volume1.18 Prev Close68.41
ShortableYes LT Debt/Eq0.37 EarningsNov 17 AMC Payout0.00% Avg Volume8.63M Price70.80
Recom1.80 SMA20-4.23% SMA50-3.32% SMA200-7.01% Volume10,206,607 Change3.49%
Nov-18-16Reiterated Wedbush Outperform $96 → $98
Nov-18-16Reiterated Mizuho Buy $85 → $95
Nov-18-16Reiterated BMO Capital Markets Outperform $86 → $90
Oct-18-16Initiated Rosenblatt Buy $90
Sep-01-16Reiterated Wedbush Outperform $98 → $96
Sep-01-16Reiterated RBC Capital Mkts Outperform $91 → $85
Sep-01-16Reiterated Mizuho Buy $100 → $85
Sep-01-16Reiterated BMO Capital Markets Outperform $98 → $86
Jun-15-16Initiated BMO Capital Markets Outperform $98
May-19-16Reiterated Wunderlich Buy $93 → $101
May-19-16Reiterated Wedbush Outperform $95 → $98
May-19-16Reiterated Stifel Buy $85 → $93
May-19-16Reiterated MKM Partners Buy $86 → $96
May-19-16Reiterated Mizuho Buy $90 → $100
May-19-16Reiterated Canaccord Genuity Buy $88 → $95
May-19-16Reiterated Barclays Overweight $88 → $89
May-17-16Reiterated Jefferies Hold $60 → $74
May-12-16Reiterated Barclays Overweight $72 → $88
Mar-04-16Initiated Macquarie Outperform
Feb-25-16Reiterated Wedbush Outperform $92 → $95
Dec-05-16 10:10PM  Asian stocks climb on strong Dow close, US service report
04:28PM  Coupa Software Earnings, Guidance Top Wall Street Expectations
03:08PM  Salesforce's Relationship With Microsoft Sours (CRM, LNKD) at Investopedia
10:31AM  Amazon and Salesforce Strengthen Global Strategic Alliance
08:15AM  Blog Coverage Amazon Web Services and Salesforce Take Their Relationship to the Next Level with the Integration of Five New Services Accesswire
01:00AM  MSFT, QLIK, ADBE: Jim Cramer's Views at TheStreet
Dec-02-16 07:01PM  Cramer: The World Hates Tech Right Now at TheStreet
06:29PM  Salesforce to Offer Core Software Tools on AWS Starting in 2017 at The Wall Street Journal
04:40PM  Workday's Disappointing Guidance Is a Major Sign the Cloud Software Industry Is Maturing
04:13PM  Will Workday Be In Play After Soft Guidance Torches Stock?
02:33PM  [video]Twitter Buys Yes, Finally Bags New Product VP
02:30PM  How Amazon's Rapidly Growing Cloud Business Threatens Microsoft and Oracle at TheStreet
08:50AM  Workday Beats But Shares Get A Beatdown at Forbes
08:47AM  Look Both Ways, Salesforce Has Reached a Technical Crossroad at TheStreet
08:08AM  AWS and Salesforce Extend Global Strategic Alliance CNW Group
08:00AM  AWS and Salesforce Extend Global Strategic Alliance PR Newswire
Dec-01-16 01:37PM  Tech stocks plunged on Thursday
12:57PM  Salesforce leads tech-sector stock sell-off at MarketWatch
10:32AM  How SAP Plans to Break Away from the Competition at Market Realist
Nov-30-16 04:25PM  One slide shows why no one can catch Amazon's cloud
04:16PM  Box Fiscal Q3 Earnings, Q4 Outlook Beat Expectations, Stock Rises
04:11PM  Salesforce is on track to become a $100 billion company in 3 years, says analyst Business Insider
12:10PM  ETFs with exposure to salesforce.com, inc. : November 30, 2016
09:00AM  Buy These 5 Stocks Now Before It's Too Late
05:00AM  KONE Selects Salesforce Service Cloud Lightning to Elevate its Customer Service PR Newswire
Nov-29-16 04:46PM  Here are the top 20 AI investors ... and their biggest 2016 deals at bizjournals.com
03:08PM  10 Cloud Computing Stats that Will Blow You Away at Motley Fool
08:15AM  Post Earnings Coverage as Salesforce.com Revenue Soared 25%; Raises Earnings Outlook Accesswire
07:39AM  salesforce.com, inc. breached its 50 day moving average in a Bearish Manner : CRM-US : November 29, 2016
Nov-28-16 04:42PM  SALESFORCE COM INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:05PM  Amazon Re:Invent: Software Deals Aim At Microsoft Cloud
04:03PM  From Cloud To Quantum Computing, Bandwidth Demand Boosts Zayo
01:21PM  In Which Cloud Provider Should I Invest?
07:30AM  Salesforce Executives to Participate in Upcoming Investor Events PR Newswire
07:00AM  Salesforce.com Is Challenging for Software Supremacy at Morningstar
Nov-26-16 01:04PM  SALESFORCE COM INC Financials
Nov-25-16 05:42PM  Top Stocks to Buy in Artificial Intelligence at Motley Fool
11:04AM  Analysts Views on Salesforces Stock
10:04AM  Salesforces Value Proposition in the Software Space
08:04AM  Has Salesforces Cash Position Improved?
Nov-24-16 11:04AM  Is Salesforce Chasing Growth at the Expense of Margins?
10:04AM  Salesforce Aims to Record More Than $10 Billion Revenue in 2018 at Market Realist
08:04AM  Salesforce Raises Guidance Again on Deferred Revenue at Market Realist
Nov-23-16 02:40PM  Will Somebody Buy Twitter in 2017? at Motley Fool
12:00PM  Top Stocks to Buy in Cloud Computing at Motley Fool
11:04AM  Salesforces Stiff Competition in the Marketing Cloud Space at Market Realist
08:15AM  Post Earnings Coverage as Mobileye Revenue Soars 34% and Earnings Jump 27% Accesswire
08:05AM  How Did Salesforces Subscription Segment Perform in 3Q17? at Market Realist
Nov-22-16 07:04PM  Why Is Salesforce Keen on Diversification?
04:37PM  What Fueled Salesforces Post-3Q17 Stock Rise?
04:00PM  5 Stocks that will Boost Your Portfolio Right Now
09:30AM  Zacks.com featured highlights: Allegheny Technologies, salesforce.com, United States Steel, Vertex Pharmaceuticals and Continental Resources
08:05AM  Can Salesforce Sustain Its Growth? at Market Realist
08:05AM  Why Did Ciscos Collaboration Revenues Fall in Fiscal 1Q17?
Nov-21-16 08:18PM  Oracle may have just launched a bargain-buying spree in tech at MarketWatch
05:21PM  SALESFORCE COM INC Files SEC form 10-Q, Quarterly Report
12:36PM  salesforce.com, inc. :CRM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2016
11:19AM  [$$] Eight Picks to Play GE's Software Push at Barrons.com
11:09AM  Salesforce.com Receives Round of Upgrades (CRM) at Investopedia
10:10AM  Company News for November 21, 2016
09:09AM  5 Toxic Stocks to Get Rid Of or Play Short Right Now
08:24AM  Is Now the Time to Buy Salesforce? at TheStreet
01:00AM  AMZN, FB, GOOGL: Jim Cramer's Views
Nov-20-16 05:25PM  How Analysts View Salesforce After Earnings 24/7 Wall St.
Nov-19-16 07:21PM  Salesforce has overcome speed bump, analysts say at MarketWatch
Nov-18-16 07:50PM  Indexes Dip But Near Highs; Watch These Top Stocks
07:01PM  Cramer: 4 Companies Have Products That Rise Above the Macro
06:33PM  Salesforce.com Revenue Surges 25% at Motley Fool
04:44PM  Gap and Abercrombie tumble; Salesforce and Ross Stores rise
04:34PM  Stocks Off, But Small Caps Rise; Macom Soars; Can Apple Break Out Again?
04:08PM  Bulls Run With Salesforce.com Beat, Revenue Guidance; Stock Jumps
02:12PM  The hidden penalty in promoting workplace diversity at CNBC
02:06PM  Salesforce CEO Marc Benioff is telling an odd story about how Microsoft tricked him Business Insider
02:01PM  Salesforce's Q3 May Prove It Doesn't Need Big Acquisitions To Grow
01:54PM  Salesforce.com Rebounds on Strong Earnings at Investopedia
01:39PM  [$$] Gap shares plunge on weaker sales and dour guidance at Financial Times
01:29PM  Salesforce Rising: The Beginning of a Software Rally? at Barrons.com
12:49PM  Salesforce sets finish line in race to $10 billion at MarketWatch
11:54AM  Buy Salesforce.com on a Pullback to $76 at TheStreet
11:23AM  Salesforce's Momentum Improves As It Heads Into A Critical Q4
10:48AM  Salesforce's Impressive Earnings Report and Guidance: What Wall Street's Saying at TheStreet
10:28AM  Jim Cramer -- Salesforce Takes Jab at Microsoft at TheStreet
10:23AM  Salesforce CEO thanks Kanye for a great quarter at MarketWatch
10:23AM  Nasdaq Hits Record High, But Backs Off; Applied Materials Recovers
10:15AM  Stock market flat as dollar continues rise; Nasdaq hits intraday record at MarketWatch
10:09AM  Nasdaq Briefly Hits Record High; Marvell, Salesforce.com Rocket
09:52AM  Tech Today: Salesforce, Marvell Surge, Apple's Inventory, Intel's A.I. at Barrons.com
09:36AM  Stocks Little Changed After Series of Retail Earnings Disappointments
09:00AM  The Market In 5 Minutes: Salesforce Has Strong Quarter, Tesla-SolarCity Deal Approved By Shareholders
08:13AM  Salesforce.com Tops Q3 Earnings Expectations (CRM) at Investopedia
08:12AM  Early movers: FL, ANF, BKE, HIBB, AAL, WFC, UPS, CRM, GPS & more at CNBC
07:48AM  Salesforce (CRM) Rises on Strong Q3 Earnings; Lifts Outlook
07:38AM  Salesforce's Last Quarter Was A 'Speed Bump'
07:17AM  If futures can turn around, it could be a record Friday at CNBC
06:00AM  Jim Cramer's Top Takeaways: Salesforce.com, Wells Fargo
05:02AM  Total and Salesforce back French internet start-up Sigfox Reuters
04:13AM  France's Sigfox raises further $160 mln for 'Internet of Things' network - source Reuters
02:11AM  Edited Transcript of CRM earnings conference call or presentation 17-Nov-16 10:00pm GMT
12:22AM  [$$] Salesforce Posts Rising Revenue, Lifts Outlook at The Wall Street Journal
Nov-17-16 09:38PM  Salesforce's revenue forecast beats estimates, shares rise
salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. It offers enterprise cloud computing applications and platform services, including Sales Cloud that enables companies to store data, monitor leads and progress, forecast opportunities, gain insights through relationship intelligence, and collaborate around sales on desktop and mobile devices. The company also provides Service Cloud that enables companies to deliver personalized customer service and support, as well as connects their service agents with customers on various devices; and Marketing Cloud, which enables companies to plan, personalize, and optimize customer interactions. In addition, it offers Community Cloud that enables companies to engage with groups of people by giving them access to information, applications, and experts; Analytics Cloud, an application, which enables companies to deploy sales, service, marketing, and custom analytics applications using various data source; Internet of Things Cloud that enables customers to process data, as well as build personalized actions and engage with customers in real time; and App Cloud, an application development platform for companies to deliver connected applications for various business needs. Further, the company provides professional services, including consulting, deployment, training, and design and integration services to facilitate the adoption of its cloud solutions, as well as offers various education service offerings ranging from introductory online courses to advanced architecture certifications. It sells and markets services primarily through its direct sales force, as well as through consulting firms, systems integrators, and regional partners. The company has a strategic alliance with Cisco to develop IoT and contact center platforms. salesforce.com, inc. was founded in 1999 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wojcicki SusanDirectorDec 05Buy69.291,44399,98720,003Dec 05 07:25 PM
Benioff MarcChairman of the Board and CEODec 05Sale70.6712,500883,32934,520,500Dec 05 07:20 PM
Benioff MarcChairman of the Board and CEODec 02Sale68.4312,500855,34234,533,000Dec 02 08:03 PM
Benioff MarcChairman of the Board and CEODec 01Sale69.5112,500868,89434,545,500Dec 01 08:13 PM
Benioff MarcChairman of the Board and CEONov 30Sale72.6112,500907,59334,558,000Nov 30 08:38 PM
Martinez MariaPres., Sales & Cust. SuccessNov 29Sale72.761,27993,06033,214Nov 30 08:32 PM
Allanson JoeChief Accounting OfficerNov 29Sale72.761,16584,76529,353Nov 30 08:34 PM
Benioff MarcChairman of the Board and CEONov 29Sale72.8412,500910,52834,570,500Nov 30 08:38 PM
Allanson JoeChief Accounting OfficerNov 28Sale73.031,31195,74330,518Nov 28 09:34 PM
Dayon AlexandrePres. & Chief Product OfficerNov 28Sale73.032,234163,15019,598Nov 28 09:36 PM
Norton Burke FEVP and Chief Legal OfficerNov 28Sale73.031,983144,82077,422Nov 28 09:38 PM
Martinez MariaPres., Sales & Cust. SuccessNov 28Sale73.033,335243,55734,493Nov 28 09:40 PM
Hawkins Mark JChief Financial OfficerNov 28Sale73.0399272,44610,906Nov 28 09:42 PM
Benioff MarcChairman of the Board and CEONov 28Sale72.9912,500912,40034,583,000Nov 28 06:23 PM
Weaver Amy EEVP, General CounselNov 28Sale73.031,03875,80615,698Nov 28 09:44 PM
Robbins Cynthia G.EVP, Global Employee SuccessNov 28Sale73.031,32696,8393,165Nov 28 09:48 PM
Harris ParkerCo-FounderNov 28Sale73.032,076151,61238,049Nov 28 09:58 PM
Allanson JoeChief Accounting OfficerNov 27Option Exercise0.001,484031,829Nov 28 09:34 PM
Norton Burke FEVP and Chief Legal OfficerNov 27Option Exercise0.001,152079,405Nov 28 09:38 PM
Martinez MariaPres., Sales & Cust. SuccessNov 27Option Exercise0.004,936037,828Nov 28 09:40 PM
Robbins Cynthia G.EVP, Global Employee SuccessNov 27Option Exercise0.0022004,491Nov 28 09:48 PM
Harris ParkerCo-FounderNov 27Option Exercise0.001,328040,125Nov 28 09:58 PM
Allanson JoeChief Accounting OfficerNov 26Option Exercise0.00452030,345Nov 28 09:34 PM
Dayon AlexandrePres. & Chief Product OfficerNov 26Option Exercise0.002,713021,832Nov 28 09:36 PM
Norton Burke FEVP and Chief Legal OfficerNov 26Option Exercise0.001,085078,253Nov 28 09:38 PM
Martinez MariaPres., Sales & Cust. SuccessNov 26Option Exercise0.00724032,892Nov 28 09:40 PM
Hawkins Mark JChief Financial OfficerNov 26Option Exercise0.001,876011,898Nov 28 09:42 PM
Weaver Amy EEVP, General CounselNov 26Option Exercise0.001,206016,736Nov 28 09:44 PM
Robbins Cynthia G.EVP, Global Employee SuccessNov 26Option Exercise0.001,20604,271Nov 28 09:48 PM
Harris ParkerCo-FounderNov 26Option Exercise0.001,085038,797Nov 28 09:58 PM
Allanson JoeChief Accounting OfficerNov 25Option Exercise0.00540029,893Nov 28 09:34 PM
Dayon AlexandrePres. & Chief Product OfficerNov 25Option Exercise0.001,512019,119Nov 28 09:36 PM
Norton Burke FEVP and Chief Legal OfficerNov 25Option Exercise0.001,512077,168Nov 28 09:38 PM
Martinez MariaPres., Sales & Cust. SuccessNov 25Option Exercise0.00648032,168Nov 28 09:40 PM
Weaver Amy EEVP, General CounselNov 25Option Exercise0.00756015,530Nov 28 09:44 PM
Robbins Cynthia G.EVP, Global Employee SuccessNov 25Option Exercise0.001,08003,065Nov 28 09:48 PM
Harris ParkerCo-FounderNov 25Option Exercise0.001,512037,712Nov 28 09:58 PM
Allanson JoeChief Accounting OfficerNov 25Sale73.7357742,54229,353Nov 28 04:56 PM
Benioff MarcChairman of the Board and CEONov 25Sale73.7512,500921,90534,595,500Nov 28 06:23 PM
Weaver Amy EEVP, General CounselNov 23Sale74.1232924,38714,774Nov 23 07:23 PM
Norton Burke FEVP and Chief Legal OfficerNov 23Sale74.121,971146,09875,656Nov 23 07:26 PM
Martinez MariaPres., Sales & Cust. SuccessNov 23Sale74.1298673,08631,520Nov 23 07:28 PM
Dayon AlexandrePres. & Chief Product OfficerNov 23Sale74.122,628194,79817,607Nov 23 07:34 PM
Allanson JoeChief Accounting OfficerNov 23Sale74.1265748,70029,930Nov 23 07:38 PM
Benioff MarcChairman of the Board and CEONov 23Sale74.0512,500925,68634,608,000Nov 23 07:41 PM
Hawkins Mark JChief Financial OfficerNov 23Sale74.121,971146,09810,022Nov 23 07:43 PM
Harris ParkerCo-FounderNov 23Sale74.121,971146,09936,200Nov 23 07:45 PM
Weaver Amy EEVP, General CounselNov 22Option Exercise0.00617015,103Nov 23 07:23 PM
Norton Burke FEVP and Chief Legal OfficerNov 22Option Exercise0.003,704077,627Nov 23 07:26 PM
Martinez MariaPres., Sales & Cust. SuccessNov 22Option Exercise0.001,852032,506Nov 23 07:28 PM
Dayon AlexandrePres. & Chief Product OfficerNov 22Option Exercise0.004,939020,235Nov 23 07:34 PM
Allanson JoeChief Accounting OfficerNov 22Option Exercise0.001,234030,587Nov 23 07:38 PM
Hawkins Mark JChief Financial OfficerNov 22Option Exercise0.003,704011,993Nov 23 07:43 PM
Harris ParkerCo-FounderNov 22Option Exercise0.003,704038,171Nov 23 07:45 PM
Benioff MarcChairman of the Board and CEONov 22Sale75.7412,500946,71534,620,500Nov 22 07:21 PM
Benioff MarcChairman of the Board and CEONov 21Sale76.4912,500956,12634,633,000Nov 21 08:12 PM
Dayon AlexandrePres. & Chief Product OfficerNov 18Option Exercise27.0633,408904,10448,704Nov 21 08:07 PM
Benioff MarcChairman of the Board and CEONov 18Sale78.0712,500975,92634,645,500Nov 18 07:12 PM
Dayon AlexandrePres. & Chief Product OfficerNov 18Sale77.9733,4082,604,71815,296Nov 21 08:07 PM
Benioff MarcChairman of the Board and CEONov 17Sale74.6612,500933,20634,658,000Nov 17 05:58 PM
Benioff MarcChairman of the Board and CEONov 16Sale73.6812,500921,00134,670,500Nov 16 06:44 PM
Norton Burke FEVP and Chief Legal OfficerNov 15Option Exercise27.06180,0004,871,250253,923Nov 15 08:30 PM
Benioff MarcChairman of the Board and CEONov 15Sale74.1512,500926,82534,683,000Nov 15 09:06 PM
Conway CraigDirectorNov 15Sale74.2425018,5608,888Nov 15 08:27 PM
Norton Burke FEVP and Chief Legal OfficerNov 15Sale74.15180,00013,347,34773,923Nov 15 08:30 PM
Allanson JoeChief Accounting OfficerNov 14Option Exercise27.0621,222574,32044,220Nov 15 09:13 PM
Benioff MarcChairman of the Board and CEONov 14Sale73.2112,500915,11534,695,500Nov 15 09:06 PM
Allanson JoeChief Accounting OfficerNov 14Sale74.5014,8671,107,65429,353Nov 15 09:13 PM
Benioff MarcChairman of the Board and CEONov 11Sale74.4412,500930,51034,708,000Nov 14 05:54 PM
Benioff MarcChairman of the Board and CEONov 10Sale74.1112,500926,40134,720,500Nov 14 05:54 PM
Benioff MarcChairman of the Board and CEONov 09Sale75.6112,500945,06334,733,000Nov 09 07:41 PM
Benioff MarcChairman of the Board and CEONov 08Sale76.5612,500956,96334,745,500Nov 08 08:12 PM
Wojcicki SusanDirectorNov 07Buy76.881,30099,94016,850Nov 08 07:57 PM
Benioff MarcChairman of the Board and CEONov 07Sale76.3812,500954,80134,758,000Nov 07 07:35 PM
Benioff MarcChairman of the Board and CEONov 04Sale74.7412,500934,23434,770,500Nov 04 07:52 PM
Benioff MarcChairman of the Board and CEONov 03Sale74.2712,500928,40434,783,000Nov 03 06:47 PM
Benioff MarcChairman of the Board and CEONov 02Sale75.1712,500939,65434,795,500Nov 02 08:26 PM
Benioff MarcChairman of the Board and CEONov 01Sale75.9712,500949,56334,808,000Nov 01 08:29 PM
Benioff MarcChairman of the Board and CEOOct 31Sale75.2812,500940,96434,820,500Nov 01 08:29 PM
Benioff MarcChairman of the Board and CEOOct 28Sale75.2012,500940,04034,833,000Oct 28 07:02 PM
Benioff MarcChairman of the Board and CEOOct 27Sale75.1512,500939,32434,845,500Oct 27 08:42 PM
Benioff MarcChairman of the Board and CEOOct 26Sale75.2312,500940,40834,858,000Oct 26 09:01 PM
Benioff MarcChairman of the Board and CEOOct 25Sale74.8712,500935,92134,870,500Oct 25 08:22 PM
Benioff MarcChairman of the Board and CEOOct 24Sale74.9512,500936,89334,883,000Oct 24 07:42 PM
Robbins Cynthia G.EVP, Global Employee SuccessOct 24Sale74.8868150,9931,985Oct 24 07:46 PM
Weaver Amy EEVP, General CounselOct 24Sale74.8868150,99314,486Oct 24 08:12 PM
Robbins Cynthia G.EVP, Global Employee SuccessOct 22Option Exercise0.001,28702,666Oct 24 07:46 PM
Weaver Amy EEVP, General CounselOct 22Option Exercise0.001,287015,167Oct 24 08:12 PM
Benioff MarcChairman of the Board and CEOOct 21Sale73.4012,500917,45334,895,500Oct 24 07:42 PM
Benioff MarcChairman of the Board and CEOOct 20Sale72.5612,500907,00134,908,000Oct 24 07:42 PM
Benioff MarcChairman of the Board and CEOOct 19Sale72.7912,500909,93534,920,500Oct 19 06:36 PM
Harris ParkerCo-FounderOct 18Option Exercise27.063,00081,18837,467Oct 18 08:06 PM
Benioff MarcChairman of the Board and CEOOct 18Sale72.9812,500912,24334,933,000Oct 18 08:01 PM
Harris ParkerCo-FounderOct 18Sale73.003,000218,98634,467Oct 18 08:06 PM
Benioff MarcChairman of the Board and CEOOct 17Sale73.1012,500913,80134,945,550Oct 17 08:14 PM
Conway CraigDirectorOct 17Sale74.1025018,5259,138Oct 17 08:17 PM
Benioff MarcChairman of the Board and CEOOct 14Sale72.3212,500904,04734,958,000Oct 14 07:09 PM
Benioff MarcChairman of the Board and CEOOct 13Sale70.8712,500885,87934,970,500Oct 13 07:41 PM
Benioff MarcChairman of the Board and CEOOct 12Sale72.3312,500904,13834,983,000Oct 12 07:17 PM
Harris ParkerCo-FounderOct 11Option Exercise27.065,000135,31339,467Oct 11 07:23 PM
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-4.94 Insider Own0.10% Shs Outstand376.42M Perf Week0.63%
Market Cap71.96B Forward P/E11.89 EPS next Y16.07 Insider Trans1.80% Shs Float374.42M Perf Month1.25%
Income-1948.30M PEG- EPS next Q3.72 Inst Own88.50% Short Float7.27% Perf Quarter-20.05%
Sales14.90B P/S4.83 EPS this Y23.00% Inst Trans-4.29% Short Ratio5.80 Perf Half Y-23.38%
Book/sh215.93 P/B0.89 EPS next Y20.15% ROA10.30% Target Price265.11 Perf Year-39.60%
Cash/sh72.77 P/C2.63 EPS next 5Y12.50% ROE18.70% 52W Range184.50 - 317.92 Perf YTD-38.82%
Dividend2.80 P/FCF30.40 EPS past 5Y-50.40% ROI-1.30% 52W High-39.87% Beta1.02
Dividend %1.46% Quick Ratio3.90 Sales past 5Y33.40% Gross Margin83.30% 52W Low3.62% ATR6.76
Employees31200 Current Ratio4.00 Sales Q/Q4.40% Oper. Margin-9.80% RSI (14)39.54 Volatility1.99% 3.46%
OptionableYes Debt/Eq0.39 EPS Q/Q52.20% Profit Margin94.40% Rel Volume0.92 Prev Close189.69
ShortableYes LT Debt/Eq0.37 EarningsNov 10 BMO Payout0.00% Avg Volume4.69M Price191.18
Recom2.00 SMA20-2.84% SMA50-11.20% SMA200-19.83% Volume4,294,554 Change0.79%
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Apr-07-16Downgrade Susquehanna Positive → Neutral
Apr-06-16Downgrade Mizuho Buy → Neutral $330 → $250
Dec-05-16 12:04PM  Allergan's Strength Lies In Its New Products And Robust Pipeline
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017 Accesswire
09:36AM  Amgen/Allergan File for EU Approval of Avastin Biosimilar
09:15AM  JP Morgan Positive on Allergan (AGN) at Investopedia
08:47AM  Amgen, Allergan File for Avastin Biosimilar in EU (AGN) at Investopedia
Dec-04-16 06:05PM  5 Healthcare Stocks Billionaires Love The Most at Insider Monkey
Dec-02-16 08:03PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline - AGN Accesswire
04:32PM  Shire Loses Ground To Allergan In Thanksgiving Week Dry-Eye Scripts
03:49PM  Oaktree Reduces, Eliminates Multiple Positions in the 3rd Quarter
10:59AM  Billionaire Investors Are Bullish On These 5 Stocks at Insider Monkey
09:53AM  Allergan & Amgen Looking for Approvals (AGN, AMGN) at Investopedia
09:33AM  Amgen, Allergan apply for European nod for Avastin biosimilar Reuters
09:00AM  Amgen And Allergan Submit Biosimilar Marketing Authorization Application To European Medicines Agency For ABP 215, A Biosimilar Candidate To Bevacizumab PR Newswire
08:36AM  Stock Futures Hold Lower After U.S. Adds 178,000 Jobs
07:30AM  Allergan Provides Update on Accelerated Share Repurchase (ASR) Program PR Newswire
07:20AM  Allergan settles patent litigation with Zydus Pharma and Cadila regarding ulcerative colitis treatment at MarketWatch
07:00AM  Allergan Announces Settlement of a DELZICOL® (mesalamine) Patent Litigation PR Newswire
Dec-01-16 05:17PM  Allergan CEO: We're in era of populism & drug industry is...
03:56PM  Pharma execs weigh in on possible changes under Trump Reuters
02:22PM  Allergan CEO expects drug industry to face pricing heat from Trump Reuters
10:31AM  The Deal Economy Event Is Live
10:19AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline - January 3, 2017 Accesswire
09:18AM  Allergan CEO: 'I worry today that pharma has a false sense of relief or security' with Trump presidency
Nov-30-16 05:03PM  Valeant-Takeda Salix Negotiations Bust On $10 Billion Price: Report
12:06PM  Allergan's CEO Signals Confidence With $1 Million Purchase Of Stock at Forbes
11:24AM  Allergan Seeks to Reassure Antsy Investors but Will They Buy It?
08:05AM  Steady Rise: Allergans International Segment in 3Q16
Nov-29-16 05:04PM  Falling Revenue in Allergans US General Medicines Segment
03:45PM  Q3 Shows Hedge Funds Abandoning Healthcare Stocks (AGN, EBAY) at Investopedia
03:04PM  Allergans US Specialized Therapeutics Segment in 3Q16
02:18PM  Pfizer (PFE) Stock Rating Upgraded at Barclays
01:27PM  Understanding Allergans 3Q16 Revenue Stream
01:26PM  Analyzing Allergans Growth Pharma Plans
01:26PM  Allergans News: Recent Acquisitions and Divestments
01:26PM  Allergans Valuation Compared to Its Peers
10:55AM  Weekly CEO Buys Highlight
07:30AM  Allergan to Present at 2016 Citi Global Healthcare Conference PR Newswire
07:00AM  Carl Icahn Nearly Exits Allergan Position in Q3 (AGN, HLF) at Investopedia
Nov-28-16 03:06PM  Top Research Reports for Alphabet, Deere & Bristol-Myers
01:11PM  5 Healthcare Stocks Hedge Funds Are Dumping Like Crazy at Insider Monkey
12:01PM  3 Stocks That Had Billionaires Running for the Exit in Q3 at Motley Fool
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline GlobeNewswire
08:49AM  Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALIOF
Nov-27-16 08:25PM  Is Nike Inc (NKE) Worthy of Your Portfolio? at Insider Monkey
06:00AM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Allergan plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit AGN GlobeNewswire
Nov-25-16 08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline AGN GlobeNewswire
06:21PM  Ken Fisher Continues to Buy Allergan, HP, Lowe's
05:12PM  [$$] Clinical Development News, Nov. 21-25 at The Wall Street Journal
02:00PM  Allergan Could Pay $1 Billion for Chase Pharma
Nov-24-16 11:28AM  Hedge Funds Arent Crazy About Accenture Plc (ACN) Anymore at Insider Monkey
Nov-23-16 05:00PM  Allergan Makes Yet Another Acquisition at Investopedia
03:50PM  FDA Approves Allergan's Xen Glaucoma Stent (AGN) at Investopedia
02:13PM  Should You Avoid Allergan, Inc. (AGN)? at Insider Monkey
01:04PM  Targeted Acquisitions Have Strengthened Tevas Generic Business
12:58PM  Allergan Buys Alzheimer's Drug Maker for $125M (AGN) at Investopedia
12:10PM  [$$] Four traders exit Paulson & Co's London office at Financial Times
10:27AM  Allergan PLC Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important Deadline in Class Action filed by Firm - AGN PR Newswire
10:03AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline - January 3, 2017 Accesswire
07:59AM  Allergan Acquires Chase Pharma, Expands CNS Portfolio
06:00AM  Jim Cramer's Top Takeaways: Home Depot, Corbus Pharmaceuticals
Nov-22-16 04:15PM  Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease PR Newswire
03:04PM  Understanding Eli Lillys Business Segments by 3Q16 Performance
02:12PM  CEO Saunders' Stake Fails to Bolster Allergan
12:27PM  Is Donald Trump a Blessing or a Curse for Big Pharma? at Motley Fool
09:41AM  The Chief Executive Officers of These Four Companies Buy Shares, Plus Insider Selling at Sanmina Corp (SANM) at Insider Monkey
08:16AM  Allergan's Fibristal Approved in Canada for Label Expansion
08:09AM  Teva's Leukemia Drug Gets EU Approval in First-Line Setting
07:35AM  Allergan Receives FDA Clearance for the XEN® Gel Stent, a New Surgical Treatment for Refractory Glaucoma PR Newswire
Nov-21-16 07:45PM  Should You Follow Ionic Capital Managements Lead And Cut Exposure To Allergan (AGN) & Three Other Stocks? at Insider Monkey
07:15PM  Allergan Plc (AGN) CEO and President Brent L Saunders Bought $992,932 of Shares
06:08PM  Jeff Auxier Expands Holdings in Chemical and Biotech Companies
04:19PM  Acorda Scrapping Stroke Drug Just 'Small Disappointment': RBC
01:35PM  Teva Pharmaceutical Expected to Report Robust Revenue in 2016
08:00AM  FIBRISTAL®, The First And Only Medication Indicated For Uterine Fibroids, Receives Approval From Health Canada For Long Term Intermittent Treatment PR Newswire
08:00AM  FIBRISTAL®, The First And Only Medication Indicated For Uterine Fibroids, Receives Approval From Health Canada For Long Term Intermittent Treatment CNW Group
Nov-20-16 09:00AM  Sales of Allergan's Older Drugs Dwindle (AGN) at Investopedia
Nov-19-16 08:10PM  Weekly Top Insider Buys Highlight for Week of Nov. 18
Nov-18-16 11:45PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Allergan plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
09:00PM  No to Closed-End Muni Bond Funds; Cara on a Run: Best of Kass
08:06PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline - AGN PR Newswire
06:45PM  NOTICE TO ALLERGAN CURRENT AND FORMER EMPLOYEES: Zamansky LLC Investigates the Allergan Savings and Investment Plan for Possible ERISA Violations Business Wire
04:42PM  Drugmaker losses pull stocks lower; small-cap surge goes on
11:22AM  Valeant: The Shorts Are Back in Town at Barrons.com
09:03AM  3 Big Drug Stocks That Billionaire Money Managers Dumped in Q3 at Motley Fool
06:22AM  Pharma Stock Roundup: Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal
Nov-17-16 03:27PM  13Fs: Nobody Holds A Monopoly On Brainpower at Forbes
01:15PM  [$$] Teva Takes a Tumble at Barrons.com
12:50PM  Hedge Funds Bought Apple, P&G in Q3; Dumped Allergan, Charter at 24/7 Wall St.
12:24PM  Top Hedge Funds Buy P&G, Apple, BABA But Shed Healthcare at Barrons.com
11:00AM  NYPD Union Goes After Drug Prices Amid DOJ Pharma Probe at Bloomberg
10:14AM  Amgen's Migraine Drug Hits Primary Endpoint in STRIVE Study
10:07AM  Carl Icahn Buys More Herbalife (HLF), Hertz (HTZ), Unloads Energy Stocks at Insider Monkey
10:00AM  The Conference Board Leading Economic Index® for Brazil, Together with Fundação Getulio Vargas (TCB/FGV Brazil LEI), Increased PR Newswire
07:30AM  Allergan to Present at Piper Jaffray 28th Annual Healthcare Conference PR Newswire
04:47AM  Amgen, Novartis aim for big, crowded migraine market after new drug data
Nov-16-16 06:13PM  John Griffin Gains 3 Positions in 3rd Quarter
01:27PM  How This Funds Bets on Allergan, Inc. (AGN), Charter Communications, Inc. (CHTR) & Two Other Stocks Pay Off? at Insider Monkey
01:04PM  ALLERGAN PLC Financials
10:02AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline - January 3, 2017 Accesswire
09:43AM  6 Things You Need to Know about Teva's (TEVA) Q3 Earnings
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, liver disease, inflammation, fibrosis, and HIV, as well as dermatology and plastic surgery, and Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, it distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians' offices. Allergan plc has a collaboration with T2 Biosystems to develop blood-based diagnostic panel for the detection of Gram-negative bacterial species. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM
ADBE Adobe Systems Incorporated daily Stock Chart
ADBE [NASD]
Adobe Systems Incorporated
IndexS&P 500 P/E51.94 EPS (ttm)1.96 Insider Own0.10% Shs Outstand496.13M Perf Week-2.44%
Market Cap50.58B Forward P/E26.57 EPS next Y3.84 Insider Trans-29.05% Shs Float494.62M Perf Month-4.87%
Income991.90M PEG1.70 EPS next Q0.86 Inst Own87.80% Short Float1.01% Perf Quarter-1.50%
Sales5.55B P/S9.11 EPS this Y135.20% Inst Trans-1.67% Short Ratio1.92 Perf Half Y3.48%
Book/sh14.60 P/B6.98 EPS next Y28.89% ROA8.20% Target Price120.58 Perf Year10.12%
Cash/sh8.96 P/C11.38 EPS next 5Y30.50% ROE13.90% 52W Range71.27 - 111.09 Perf YTD8.53%
Dividend- P/FCF29.09 EPS past 5Y-3.40% ROI7.40% 52W High-8.23% Beta1.09
Dividend %- Quick Ratio2.20 Sales past 5Y4.80% Gross Margin85.50% 52W Low43.05% ATR2.16
Employees13893 Current Ratio2.20 Sales Q/Q20.20% Oper. Margin23.60% RSI (14)41.06 Volatility2.58% 2.14%
OptionableYes Debt/Eq0.00 EPS Q/Q55.90% Profit Margin17.90% Rel Volume0.90 Prev Close99.73
ShortableYes LT Debt/Eq0.26 EarningsDec 20 AMC Payout0.00% Avg Volume2.58M Price101.95
Recom1.90 SMA20-2.51% SMA50-4.49% SMA2003.35% Volume2,319,324 Change2.23%
Nov-03-16Reiterated Wunderlich Hold $99 → $115
Sep-21-16Reiterated RBC Capital Mkts Outperform $115 → $116
Sep-21-16Reiterated Pivotal Research Group Buy $124 → $125
Jul-26-16Initiated Piper Jaffray Overweight $125
Jun-22-16Reiterated UBS Buy $114 → $122
Jun-22-16Reiterated Rosenblatt Buy $112 → $120
Apr-21-16Resumed Credit Suisse Neutral $85 → $105
Apr-12-16Reiterated FBR Capital Mkt Perform $100 → $115
Apr-04-16Reiterated Dougherty & Company Buy $116 → $122
Mar-31-16Initiated Canaccord Genuity Buy $110
Mar-18-16Reiterated Wunderlich Hold $94 → $99
Mar-18-16Reiterated UBS Buy $105 → $114
Mar-18-16Reiterated RBC Capital Mkts Outperform $101 → $104
Mar-18-16Reiterated Dougherty & Company Buy $114 → $116
Jan-14-16Initiated Dougherty & Company Buy $114
Dec-14-15Reiterated Argus Buy $95 → $110
Dec-11-15Reiterated Wunderlich Hold $90 → $94
Dec-11-15Reiterated RBC Capital Mkts Outperform $100 → $112
Dec-11-15Reiterated Pivotal Research Group Buy $95 → $104
Dec-11-15Reiterated KeyBanc Capital Mkts Overweight $90 → $110
Dec-06-16 12:03AM  Ikea to offer expanded parental leave in stronger job market AP
Dec-05-16 05:32PM  Worker pleads guilty to snooping on emails for stock deals AP
03:11PM  Zacks Reduces Rating of Adobe Systems (ADBE) at Investopedia
10:50AM  Reliance Trust Lowers Position in Adobe (ADBE) at Investopedia
Dec-03-16 01:40PM  Hasbro's Pie Face Showdown Is Top Toy so Far This Year, Amazon Says
Dec-02-16 07:01PM  Cramer: Some Stocks Aren't Following the Script at TheStreet
05:06PM  Are Candlestick Charts Lighting the Way for Splunk? at TheStreet
04:52PM  We May Have Caught a Low on Adobe Systems at TheStreet
02:30PM  How Amazon's Rapidly Growing Cloud Business Threatens Microsoft and Oracle at TheStreet
06:00AM  Jim Cramer's Top Takeaways: Henry Schein, CBRE
Dec-01-16 05:31PM  New wave of tech leases boosts S.F. office market at bizjournals.com
05:21PM  Heres What Smart Money Thinks about Dominion Resources, Inc. (D) at Insider Monkey
04:49PM  4 changes shoppers will see as they buy on their phones AP
02:04PM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of The Board of Directors of TubeMogul - TUBE PR Newswire
01:08PM  Cohen Klingenstein Keeps Stake in Adobe (ADBE) at Investopedia
Nov-30-16 05:20PM  Palladium Partners Ups Stake in Adobe (ADBE) at Investopedia
12:34PM  Amica Maintains Stake in Adobe Systems (ADBE) at Investopedia
10:35AM  Adobe Compiled Data Reveal Record Cyber Monday Sales
08:02AM  Pennsylvania Trust Adds ADBE Shares in 3Q16 (ADBE) at Investopedia
Nov-29-16 05:12PM  Amazon Devices Were Amazon's Top Sellers Over Thanksgiving Weekend
04:01PM  Cyber Monday, Black Friday Set Online Sales Records
01:51PM  National Pension Service Ups Stake in Adobe (ADBE) at Investopedia
11:50AM  Cyber Monday Narrowly Holds Off Black Friday as America's Biggest Online Shopping Day
10:44AM  Prudential Financial Lowers Stake in ADBE (ADBE) at Investopedia
09:51AM  Cyber Monday sets new record with $3.45 billion in online sales at MarketWatch
08:32AM  ICON Advisers Raises Stake in Adobe Systems (ADBE) at Investopedia
06:30AM  A 'social media company' and 'foreign telecom company' were interested in buying TubeMogul before Adobe swooped in with its $540 million offer Business Insider
Nov-28-16 10:52PM  Cyber Monday Is Still King Of Online Sales, But Just Barely
08:07PM  Cyber Monday transforms as shoppers are more connected AP
08:00PM  Media Alert: Adobe Data Shows Cyber Monday Largest Online Sales Day in History With $3.39 Billion Business Wire
07:01PM  Cramer: Has Retail Really Righted Itself?
04:05PM  Amazon Re:Invent: Software Deals Aim At Microsoft Cloud
12:27PM  Vetr Lowers Adobe Systems to Hold Rating (ADBE) at Investopedia
12:27PM  Apple: Black Friday, Cyber Monday Should Pay Off Well, Says Drexel at Barrons.com
12:00PM  U.S. Shares Lower on Cyber Monday Morningstar
11:34AM  Cyber Monday to Remain Biggest Online Spending Day at Bloomberg
11:26AM  Cyber Monday Poised to Be Biggest Online Shopping Day in History
10:18AM  These Are Black Friday's Winners and Losers at Motley Fool
09:49AM  Adobe Systems Appears Set to Frustrate Bulls at TheStreet
08:32AM  BB&T Reduces Stake in Adobe Systems (ADBE) at Investopedia
08:01AM  Toronto-Dominion Bank Ups Stake in ADBE (TD, ADBE) at Investopedia
07:00AM  Salesforce.com Is Challenging for Software Supremacy at Morningstar
Nov-27-16 02:22PM  Should You Buy Adobe Systems Incorporated (ADBE)? at Insider Monkey
Nov-26-16 02:44PM  Lego, iPad Drive Record Online Sales on Black Friday, Adobe Says at Bloomberg
02:44PM  Lego, iPad Drive Record Online Sales on Black Friday, Adobe Says
12:04PM  Media Alert: Adobe Data Shows Black Friday Breaks Online Sales Record With $3.34 Billion Business Wire
Nov-25-16 07:28PM  Black Friday Deals, Thanksgiving Sales, Fuel Online Buying
03:25PM  The Latest: online, in malls and overseas, Black Friday's on
12:31PM  Mattel Brands Selling Fast at Toys 'R' Us on Black Friday
12:06PM  Online spending falls short of expectations on Thanksgiving, despite record days for some at CNBC
11:43AM  U.S. online sales tally more than $1 billion on Thanksgiving Day at MarketWatch
09:05AM  Early signs bullish on Black Friday
08:27AM  The Trade Desk Makes it to Deloitte's Technology Fast 500 List
Nov-23-16 04:40PM  "Joy" or "hope"? Holiday giving may depend on how you voted
01:28PM  After Sharp Q2 Fall, Hedge Fund Interest in Express Scripts Holding Company (ESRX) Rebounds in Q3 at Insider Monkey
11:04AM  Salesforces Stiff Competition in the Marketing Cloud Space at Market Realist
10:04AM  Why Did Adobe Acquire TubeMogul? at Market Realist
08:08AM  On BizWireTV: Black Friday Shopping Expected to Break Records and the Worlds Largest Digital Safety Platform Business Wire
Nov-22-16 02:15PM  Zacks Lowers Rating of Adobe Systems Shares (ADBE) at Investopedia
06:05AM  Western Digital, Sears, Adobe Among 5 Stocks Breaking Out
Nov-21-16 04:30PM  3 Cloud Stocks To Buy Right Now
10:00AM  Adobe Named a Leader in Lead-to-Revenue Management Platform Vendors by Independent Research Firm Business Wire
09:19AM  Water Corp.'s Momentum Intact on Solid Biopharma Prospects
08:52AM  Capital Investment Services Cuts Adobe Stake (ADBE) at Investopedia
12:28AM  Wal-Mart kicks off Cyber Monday on Friday
Nov-20-16 11:00AM  [$$] Mobile to take lead role in US retail this holiday season at Financial Times
Nov-18-16 04:44PM  Pitney Bowes Geospatial API Available on AWS Marketplace
10:31AM  Wait for Adobe to Test Support Before Going Long at TheStreet
10:14AM  The Election Has Hurt Online Retail Sales at Motley Fool
08:08AM  On BizWireTV: CES 2017 Announces Best of Innovation Honorees and a New Game to Aid Better Sleep Business Wire
Nov-17-16 07:09PM  Jim Cramer's 'Mad Money' Recap: Focusing on Trump's Impact on This Market at TheStreet
12:47PM  Adobe Fined $1 Million After 2013 Hack (ADBE) at Investopedia
09:16AM  Adobe's Upside Is Already Priced In; BTIG Initiates At Neutral
09:02AM  The Market In 5 Minutes: Wal-Mart, Cisco Disappoint Investors
08:02AM  SAP Pursues Partnerships to Drive Innovation and Growth
Nov-16-16 03:45PM  Sell These 5 Stocks Now Before its Too Late
Nov-15-16 09:22AM  Calls are betting on bounce in Adobe
08:22AM  Amalgamated Bank Increases Stake in Adobe (ADBE) at Investopedia
Nov-14-16 06:03PM  Kilroy (KRC) Picks Adobe as Anchor Tenant for 100 Hooper
Nov-11-16 09:09AM  Adobe to Boost Digital Marketing with TubeMogul Buyout
08:15AM  Blog Coverage Adobe Expands its Video Content Portfolio and Announces Acquisition of TubeMogul Accesswire
Nov-10-16 05:23PM  Adobe Systems to Boost Marketing Footprint With TubeMogul at TheStreet
04:40PM  Adobe to Acquire TubeMogul for $540 Million at Investopedia
04:03PM  Adobe Systems To Buy TubeMogul For $540 Million
02:18PM  Adobe Furthers Marketing Software Ambitions with TubeMogul Acquisition at The Wall Street Journal
01:00PM  Investor Advisory: Adobe Announces Webcast of Investor Conference Participation Business Wire
12:53PM  Adobe to pay $540M for Bay Area video ad platform provider at bizjournals.com
12:24PM  TubeMogul Stock Nearly Doubles on Adobe Acquisition at Motley Fool
11:35AM  Adobe Systems to Acquire TubeMogul at TheStreet
10:43AM  Shares of TubeMogul skyrocket after Adobe acquisition at CNBC
10:15AM  Adobe's Acquisition Of TubeMogul Validates DSP TV Model
09:41AM  Photoshop maker Adobe to buy video ad firm TubeMogul Reuters
08:28AM  Photoshop maker Adobe to buy video ad firm TubeMogul for $540 million
08:24AM  Photoshop maker Adobe to buy video ad firm TubeMogul for $540 mln Reuters
08:13AM  Adobe to buy video advertising platform TubeMogul for about $540 million at MarketWatch
08:05AM  Adobe to Acquire TubeMogul Business Wire
Nov-09-16 07:00AM  ViaSat (VSAT) Posts Earnings in Q2, Revenues Top Estimates
Nov-07-16 11:31AM  A Look at Microsoft vs. Adobe (MSFT, ADBE) at Investopedia
Nov-06-16 11:40AM  Facebook, Big Tech Helping Prep You for Election Day--Tech Roundup at TheStreet
Nov-04-16 09:45AM  Merrill Lynch Raises Price Targets on 4 Red-Hot Stocks to Buy at 24/7 Wall St.
Adobe Systems Incorporated operates as a diversified software company worldwide. Its Digital Media segment provides tools and solutions that enable individuals, small and medium businesses, and enterprises to create, publish, promote, and monetize their digital content. This segment's flagship product is Creative Cloud, a subscription service that allows customers to download and install the latest versions of its creative products. This segment serves traditional content creators, Web application developers, and digital media professionals, as well as their management in marketing departments and agencies, companies, and publishers. The company's Digital Marketing segment offers solutions for how digital advertising and marketing are created, managed, executed, measured, and optimized. This segment provides analytics, social marketing, targeting, media optimization, digital experience management, cross-channel campaign management, and audience management solutions, as well as video delivery and monetization to digital marketers, advertisers, publishers, merchandisers, Web analysts, chief marketing officers, chief information officers, and chief revenue officers. Its Print and Publishing segment offers products and services, such as eLearning solutions, technical document publishing, Web application development, and high-end printing, as well as publishing needs of technical and business, and original equipment manufacturers (OEMs) printing businesses. The company markets and licenses its products and services directly to enterprise customers through its sales force, as well as to end-users through app stores and through its Website at adobe.com. It also distributes products and services through a network of distributors, value-added resellers, systems integrators, independent software vendors, retailers, and OEMs. Adobe Systems Incorporated has a strategic partnership with comScore, Inc. The company was founded in 1982 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morris DonnaEVP, Cust. & Emp. ExperienceOct 10Sale110.0010,0001,100,00054,279Oct 11 04:43 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryOct 10Sale109.6413,3311,461,57930,993Oct 11 04:41 PM
WARNOCK JOHN ECo-Chairman of the BoardSep 27Sale106.995,000534,950571,600Sep 27 04:49 PM
ROSENSWEIG DANIELDirectorSep 26Sale107.4213,0001,396,4266,268Sep 27 04:47 PM
DALEY JAMES EDirectorSep 22Option Exercise33.236,276208,55134,362Sep 23 05:00 PM
DALEY JAMES EDirectorSep 22Sale108.006,276677,80828,086Sep 23 05:00 PM
GARRETT MARKEVP, CFO & Asst. SecretarySep 06Sale103.4726,8992,783,3120Sep 06 07:01 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryAug 29Sale101.855,450555,08344,324Aug 29 06:11 PM
Lewnes AnnEVP, Chief Marketing OfficerAug 26Sale101.6813113,32042,968Aug 29 04:29 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryAug 23Option Exercise0.0027,500064,123Aug 24 04:08 PM
GARRETT MARKEVP, CFO & Asst. SecretaryAug 16Option Exercise0.0056,250056,250Aug 17 04:31 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Option Exercise34.032,33579,46076,614Aug 11 04:05 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Sale100.0010,0001,000,00064,279Aug 11 05:06 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Sale100.002,335233,50074,279Aug 11 04:05 PM
Lewnes AnnEVP, Chief Marketing OfficerJul 29Sale98.404,000393,60043,099Aug 01 04:09 PM
DALEY JAMES EDirectorJul 20Option Exercise33.235,000166,15033,086Jul 21 04:08 PM
WARNOCK JOHN ECo-Chairman of the BoardJul 20Sale98.512,000197,024579,115Jul 21 04:10 PM
DALEY JAMES EDirectorJul 20Sale98.505,000492,50028,086Jul 21 04:08 PM
BARNHOLT EDWARD WDirectorJul 11Option Exercise37.0925,000927,25058,124Jul 11 05:56 PM
BARNHOLT EDWARD WDirectorJul 11Sale97.2525,0002,431,13333,124Jul 11 05:56 PM
Rencher BradleyEVP & GM, Digital MarketingJul 01Sale95.4637,5623,585,62747,269Jul 01 05:38 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJul 01Sale95.6827125,9291,348Jul 01 04:13 PM
LAMKIN BRYANEVP & GM, Digital MediaJul 01Sale95.049,616913,90523,665Jul 01 04:10 PM
WARNOCK JOHN ECo-Chairman of the BoardJun 30Sale95.154,000380,605581,115Jul 01 04:09 PM
ROSENSWEIG DANIELDirectorJun 29Sale92.9819,3001,794,57419,268Jul 11 04:57 PM
Lewnes AnnEVP, Chief Marketing OfficerJun 24Sale92.394,000369,56046,828Jun 24 04:32 PM
Lewnes AnnEVP, Chief Marketing OfficerMay 27Sale99.404,000397,59650,828May 31 04:09 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryMay 10Sale95.099,466900,16736,409May 11 04:17 PM
Lewnes AnnEVP, Chief Marketing OfficerApr 29Sale92.894,000371,56054,828May 02 04:29 PM
WARNOCK JOHN ECo-Chairman of the BoardApr 12Option Exercise0.003,4260581,129Apr 14 04:49 PM
CALDERONI FRANKDirectorApr 12Option Exercise0.003,426021,051Apr 14 04:47 PM
BARNHOLT EDWARD WDirectorApr 12Option Exercise0.003,426033,124Apr 14 04:45 PM
Desmond LauraDirectorApr 12Option Exercise0.003,426021,051Apr 14 04:43 PM
BURGESS ROBERT KDirectorApr 12Option Exercise0.003,426038,124Apr 14 04:42 PM
Banse AmyDirectorApr 12Option Exercise0.003,426027,791Apr 14 04:36 PM
ROSENSWEIG DANIELDirectorApr 12Option Exercise0.003,426051,568Apr 14 04:34 PM
DALEY JAMES EDirectorApr 12Option Exercise0.003,426028,086Apr 14 04:32 PM
GESCHKE CHARLES MCo-Chairman of the BoardApr 12Option Exercise0.003,4260299,973Apr 14 04:27 PM
Barlow Kelly JDirectorApr 12Option Exercise0.003,42603,426Apr 13 06:23 PM
SEDGEWICK ROBERTDirectorApr 12Option Exercise0.003,426079,347Apr 13 05:22 PM
CANNON MICHAEL RDirectorApr 12Option Exercise0.003,426033,124Apr 13 05:20 PM
WARNOCK JOHN ECo-Chairman of the BoardApr 12Sale93.295,000466,458577,703Apr 12 05:32 PM
ROWLEY RICHARDVP, Corp. Controller & CAOApr 09Option Exercise0.002,81702,817Apr 12 05:34 PM
DALEY JAMES EDirectorApr 01Option Exercise33.825,000169,10029,660Apr 01 07:35 PM
NARAYEN SHANTANUPresident and CEOApr 01Option Exercise34.0322,422763,021321,394Apr 01 07:31 PM
ROWLEY RICHARDVP, Corp. Controller & CAOApr 01Sale95.058,780834,5500Apr 01 07:28 PM
NARAYEN SHANTANUPresident and CEOApr 01Sale94.8522,4222,126,678298,972Apr 01 07:31 PM
DALEY JAMES EDirectorApr 01Sale95.005,000475,00024,660Apr 01 07:35 PM
ValueAct Holdings, L.P.DirectorMar 31Sale93.992,767,739260,127,4666,000Mar 31 05:43 PM
DALEY JAMES EDirectorMar 30Option Exercise33.822,84096,04927,500Apr 01 07:35 PM
DALEY JAMES EDirectorMar 30Sale94.002,840266,96024,660Apr 01 07:35 PM
ValueAct Holdings, L.P.DirectorMar 30Sale93.764,000,000375,040,0002,773,739Mar 31 05:43 PM
ValueAct Holdings, L.P.DirectorMar 29Sale92.971,965,580182,739,9736,773,739Mar 31 05:43 PM
ValueAct Holdings, L.P.DirectorMar 28Sale92.53100,0009,253,0008,739,319Mar 28 05:06 PM
ValueAct Holdings, L.P.DirectorMar 24Sale92.51821,80876,025,4588,839,319Mar 28 05:06 PM
ROWLEY RICHARDVP, Corp. Controller & CAOMar 24Sale92.464,146383,3498,780Mar 25 05:06 PM
Morris DonnaEVP, Cust. & Emp. ExperienceMar 22Sale93.0025,0002,325,00074,008Mar 23 04:38 PM
GESCHKE CHARLES MCo-Chairman of the BoardMar 21Option Exercise42.6125,0001,065,250321,547Mar 23 04:33 PM
WARNOCK JOHN ECo-Chairman of the BoardMar 21Sale92.709,000834,309587,703Mar 23 04:35 PM
GESCHKE CHARLES MCo-Chairman of the BoardMar 21Sale92.4825,0002,311,875296,547Mar 23 04:33 PM
Lewnes AnnEVP, Chief Marketing OfficerFeb 26Sale86.314,000345,23362,828Feb 29 06:02 PM
Lewnes AnnEVP, Chief Marketing OfficerFeb 03Option Exercise34.032,28077,58866,828Feb 05 04:14 PM
NARAYEN SHANTANUPresident and CEOFeb 01Option Exercise34.0322,422763,021321,394Feb 02 04:35 PM
NARAYEN SHANTANUPresident and CEOFeb 01Sale88.8022,4221,991,007298,972Feb 02 04:35 PM
ValueAct Holdings, L.P.DirectorJan 29Sale89.01185,00016,466,85011,773,739Feb 02 04:31 PM
Lewnes AnnEVP, Chief Marketing OfficerJan 29Sale86.234,000344,90264,548Feb 01 04:37 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 29Sale86.2510,310889,28045,875Feb 01 04:31 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 26Sale86.8473,0006,338,99951,718Jan 27 04:34 PM
ValueAct Holdings, L.P.DirectorJan 25Sale89.005,000445,00011,958,739Jan 25 06:25 PM
GARRETT MARKEVP, CFO & Asst. SecretaryJan 25Sale88.5253,3954,726,7490Jan 27 04:43 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 24Option Exercise0.0061,567074,673Jan 27 04:45 PM
GARRETT MARKEVP, CFO & Asst. SecretaryJan 24Option Exercise0.00108,359078,348Jan 27 04:43 PM
Morris DonnaEVP, Cust. & Emp. ExperienceJan 24Option Exercise0.0076,4750121,109Jan 27 04:41 PM
LAMKIN BRYANEVP & GM, Digital MediaJan 24Option Exercise0.0017,184027,464Jan 27 04:39 PM
Rencher BradleyEVP & GM, Digital MarketingJan 24Option Exercise0.00108,2000112,252Jan 27 04:36 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 24Option Exercise0.00149,3590169,665Jan 27 04:34 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJan 24Option Exercise0.0020,930017,893Jan 27 04:32 PM
Lewnes AnnEVP, Chief Marketing OfficerJan 24Option Exercise0.0076,475090,649Jan 27 04:28 PM
ValueAct Holdings, L.P.DirectorJan 22Sale89.271,612,000143,903,24011,963,739Jan 25 06:25 PM
ValueAct Holdings, L.P.DirectorJan 21Sale89.56435,00038,958,60013,575,739Jan 25 06:25 PM
NARAYEN SHANTANUPresident and CEOJan 04Option Exercise34.0322,422763,021299,025Jan 05 04:33 PM
NARAYEN SHANTANUPresident and CEOJan 04Sale91.2422,4222,045,843276,603Jan 05 04:33 PM
SHPG Shire plc daily Stock Chart
SHPG [NASD]
Shire plc
Index- P/E66.39 EPS (ttm)2.66 Insider Own0.10% Shs Outstand294.36M Perf Week0.89%
Market Cap51.92B Forward P/E11.59 EPS next Y15.22 Insider Trans0.00% Shs Float181.26M Perf Month6.02%
Income411.00M PEG4.36 EPS next Q3.26 Inst Own23.10% Short Float0.87% Perf Quarter-9.29%
Sales9.31B P/S5.58 EPS this Y-59.40% Inst Trans-5.88% Short Ratio1.20 Perf Half Y-8.07%
Book/sh99.26 P/B1.78 EPS next Y17.64% ROA0.30% Target Price241.69 Perf Year-13.86%
Cash/sh2.48 P/C71.26 EPS next 5Y15.23% ROE0.80% 52W Range146.88 - 209.69 Perf YTD-13.53%
Dividend0.80 P/FCF- EPS past 5Y16.50% ROI12.00% 52W High-15.88% Beta1.48
Dividend %0.45% Quick Ratio0.60 Sales past 5Y13.10% Gross Margin67.60% 52W Low20.09% ATR4.52
Employees5548 Current Ratio1.30 Sales Q/Q108.60% Oper. Margin6.30% RSI (14)47.65 Volatility1.80% 2.01%
OptionableYes Debt/Eq0.80 EPS Q/Q-150.90% Profit Margin1.60% Rel Volume0.65 Prev Close174.80
ShortableYes LT Debt/Eq0.70 EarningsNov 01 BMO Payout42.60% Avg Volume1.31M Price176.39
Recom1.70 SMA20-0.31% SMA50-3.66% SMA200-3.40% Volume853,142 Change0.91%
Dec-02-16Initiated Societe Generale Buy
Sep-26-16Downgrade HSBC Securities Buy → Hold
Jun-03-16Reiterated Jefferies Buy $223 → $262
May-26-16Initiated Stifel Buy $230
May-06-16Initiated Liberum Buy
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-10-16Upgrade RBC Capital Mkts Sector Perform → Outperform $240 → $240
Feb-10-16Initiated Guggenheim Neutral
Jan-15-16Upgrade BofA/Merrill Neutral → Buy
Jan-12-16Upgrade Credit Suisse Neutral → Outperform
Jan-12-16Reiterated RBC Capital Mkts Sector Perform $248 → $240
Nov-17-15Upgrade Leerink Partners Mkt Perform → Outperform $239
Nov-03-15Upgrade HSBC Securities Hold → Buy
Oct-26-15Reiterated RBC Capital Mkts Sector Perform $263 → $248
Oct-14-15Initiated Northland Capital Outperform $288
Sep-30-15Upgrade HSBC Securities Reduce → Hold
Aug-06-15Downgrade Exane BNP Paribas Outperform → Neutral
Jul-16-15Resumed Berenberg Buy
Apr-29-15Initiated Exane BNP Paribas Outperform
Jan-26-15Reiterated RBC Capital Mkts Sector Perform $238 → $248
Dec-05-16 08:15AM  Blog Coverage Shire Announced Successful Results of its Phase III Investigational Study of VONVENDI(TM) Accesswire
Dec-04-16 06:05PM  5 Healthcare Stocks Billionaires Love The Most at Insider Monkey
Dec-02-16 05:21PM  Shire Reports on Four Decades of Real-World Safety Experience With FEIBA® PR Newswire
04:32PM  Shire Loses Ground To Allergan In Thanksgiving Week Dry-Eye Scripts
04:16PM  SHIRE PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
11:02AM  Topline Results of Phase 3 Investigational Study of VONVENDI Meets Primary Endpoint Effectively Controlling Bleeding and Blood Loss During Surgical Procedures PR Newswire
08:36AM  Coverage initiated on Shire plc by Societe Generale
Dec-01-16 04:29PM  John Paulson's Largest 3rd Quarter Trades
12:42PM  Is Smart Money Turning More Positive on Bed Bath & Beyond Inc. (BBBY)? at Insider Monkey
09:30AM  What Does Smart Money Think about Avery Dennison Corp (AVY)? at Insider Monkey
Nov-30-16 09:58AM  Momenta/Shire's Humira Biosimilar Meets Study Objective
Nov-29-16 08:23AM  Momenta stock jumps nearly 10% on positive late-stage results for Humira biosimilar at MarketWatch
Nov-28-16 04:34PM  Amicus Tumbles on Lengthy Delay to U.S. Fabry Drug FDA Filing Plan
01:11PM  5 Healthcare Stocks Hedge Funds Are Dumping Like Crazy at Insider Monkey
Nov-25-16 05:18AM  Actelion Soars as Johnson & Johnson 'Makes Takeover Proposal'
Nov-24-16 03:31PM  Do Hedge Funds Love PulteGroup, Inc. (PHM)? at Insider Monkey
Nov-23-16 04:00PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
01:42PM  Top Investors Are Abandoning Shire PLC (SHPG) in Droves at Insider Monkey
Nov-22-16 10:29AM  Shire to lease Genzyme headquarters, plans to hire another 400 at bizjournals.com
07:00AM  Shire to Establish Rare Disease Innovation Hub in Cambridge, Mass. PR Newswire
Nov-21-16 02:20PM  Hayman Capital Closes Huge McDonalds (MCD) Put Position, Turns Its Bearish Gaze on This Health Stock at Insider Monkey
Nov-17-16 11:10PM  Shire Launches Cuvitru in U.S. for Primary Immunodeficiency
Nov-16-16 07:00AM  Shire Launches CUVITRU in the U.S. for Primary Immunodeficiency PR Newswire
Nov-14-16 09:57AM  Trump Supporters Icahn, Paulson Score Huge Returns After Election Win at Insider Monkey
Nov-12-16 07:00AM  Tolerability Data for Shire's CUVITRU Accepted for Oral Presentation at the American College Of Allergy, Asthma & Immunology Annual Meeting PR Newswire
Nov-10-16 05:29PM  5 Stocks to Watch on Icahn & Paulson's Gain from Trump Win
01:04PM  SHIRE PLC Financials
07:00AM  Shire's Investor Day Showcases Strength of Rare Disease Pipeline and Commercial Portfolio PR Newswire
02:37AM  Pharma stocks propel European stocks higher after Trump win shakes markets at MarketWatch
Nov-09-16 12:24PM  FTSE 100 ends roller-coaster day higher as Trump win boosts pharma, gold shares at MarketWatch +11.50%
09:52AM  Why Merrimack Pharmaceuticals, Inc. Shares Sank 18% Lower in October at Motley Fool
Nov-07-16 12:59PM  ETFs with exposure to Shire Plc : November 7, 2016
Nov-05-16 12:12AM  [$$] Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson at The Wall Street Journal
Nov-04-16 07:21PM  Samuel Isaly Makes 9 New Buys in 3rd Quarter
11:00AM  Broad Range of Research to be Presented at ASH 2016 Demonstrates Shire's Commitment to Addressing Unmet Needs for Patients with Rare Hematologic and Specialty Conditions PR Newswire
10:04AM  Shire Plc :SHPG-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016
07:00AM  Shire to Highlight Focus on Rare Disease Innovation at Investor Day PR Newswire
Nov-02-16 04:54PM  SHIRE PLC Files SEC form 10-Q, Quarterly Report
03:32PM  [$$] Shire Hit by Fall in Sales of Hemophilia Drugs at The Wall Street Journal
10:02AM  How trader is playing upside in Shire
08:13AM  Shire (SHPG) Misses Q3 Earnings & Revenue Estimates
08:05AM  An Update on Phase 3 Studies for Soliris
08:00AM  10 Most Successful Investors in the World at Insider Monkey
Nov-01-16 02:21PM  [$$] Shire misses sales target and is hit by costs from Baxalta deal at Financial Times
01:19PM  European Stock Markets Fall As Bond Sell Off Hits Dividend Yielders Across The Board
09:16AM  FTSE 100 wobbles as Shell rises but Shire, Standard Chartered slide at MarketWatch
08:47AM  Shire reports 3Q loss
08:37AM  Shire Reports Q3 2016 Results with Record Revenues and Reiterates Full Year Non GAAP Guidance PR Newswire
08:05AM  SHIRE PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Oct-31-16 03:55PM  5 Healthcare Stocks Poised to Trump Q3 Earnings
09:48AM  Should You Buy Shire plc (SHPG) Ahead of Earnings?
08:50AM  Celldex (CLDX): Will the Stock Surprise in Q3 Earnings?
Oct-30-16 09:50AM  Week Ahead: Fed Meeting, Jobs Report Paint Clearer Picture for Rate Hike Chances
Oct-28-16 03:44PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Oct-27-16 07:00AM  Results from Shire's Phase 2 Study of Maribavir Showed Activity Against CMV Infection in Patients Undergoing Transplant PR Newswire
Oct-20-16 10:58AM  Shire Plc : SHPG-US: Dividend Analysis : September 09th, 2016 (record date) : By the numbers : October 20, 2016
Oct-19-16 04:49PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
07:55AM  Shire Cancer Drug Onivyde Receives EU Marketing Approval
Oct-18-16 11:48AM  Merrimack's Cancer Drug Wins EU Nod (MACK, SHPG) at Investopedia
11:12AM  Weighing Vertex Pharmaceuticals Attributes before It Reports
08:35AM  Shire (SHPG) Updates Vyvanse Label with New Efficacy Data
07:47AM  PharmaEngine Announces Onivyde(R) Receives European Marketing Authorization for the Treatment of Metastatic Adenocarcinoma of the Pancreas Following Gemcitabine based Therapy PR Newswire
06:45AM  Pancreatic cancer drug developed in the Bay State approved in Europe at bizjournals.com
02:00AM  Shire Granted EU Marketing Authorization of Onivyde®, in Combination With 5-Fluorouracil (5-FU) and Leucovorin (LV),for the Treatment of Metastatic Adenocarcinoma of the Pancreas in Adult Patients Who Have Progressed Following Gemcitabine-B PR Newswire
Oct-17-16 04:13PM  Eli Lilly, AbbVie Top 2017 Rankings; Pfizer, AstraZeneca Flailing
11:31AM  Pardon Me, but I Have a Few Things to Say... Trump, Bernie, Radius, Ariad
08:05AM  Multimedia Assets Available: Modern Technology and a Multi-Screen Lifestyle Viewed as Important Factors in Rising Prevalence of Dry Eye Disease PR Newswire
08:00AM  Modern Technology and a Multi-Screen Lifestyle Viewed as Important Factors in Rising Prevalence of Dry Eye Disease PR Newswire
07:00AM  Shire Announces Update to Vyvanse® (lisdexamfetamine dimesylate) U.S. Labeling to Include New Longer-Term Maintenance of Efficacy Data in Adults with Moderate to Severe Binge Eating Disorder PR Newswire
Oct-15-16 02:44AM  [$$] Baxalta Could Boost Shire Shares More Than 25% at Barrons.com
Oct-14-16 04:15PM  Shire Routs Incumbent Allergan In Booming Dry-Eye Market: RBC
10:23AM  BioMarin Issues Encouraging Update on Hemophilia A Drug
Oct-13-16 04:41PM  How Risky Is Merrimack Pharmaceuticals Stock? at Motley Fool
08:04AM  In Depth Review of Gilead Sciences NASH Pipeline Opportunities
Oct-12-16 05:49PM  Martin Whitman's Top Recent Investments
09:41AM  Merrimack's Onivyde Positive in Pancreatic Cancer Study
Oct-11-16 08:00PM  Shire plc to Join the NASDAQ-100 Index Beginning October 19, 2016 GlobeNewswire
04:18PM  Allergan Challenges Intercept With Tobira NASH Drug
07:30AM  Final Results of NAPOLI-1 Study Confirm Overall Survival and Progression-Free Survival Benefit for the ONIVYDE® Regimen for Patients with Metastatic Pancreatic Cancer PR Newswire
Oct-10-16 09:40AM  Kamada (KMDA) Extends Partnership with Shire for Glassia
09:30AM  The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Shire, Johnson & Johnson and Supernus Pharmaceuticals
08:10AM  Barron's Picks And Pans: eBay, Shire, Samsung And More
Oct-09-16 01:12PM  These Are US Hedge Funds Favorite European Stocks at Insider Monkey
Oct-07-16 04:21PM  BioMarin, Incyte, Kite Get Thumbs Up On Goldman Sachs Upgrade
09:57AM  5 Stock Picks Ahead of World Mental Health Day
09:30AM  The Zacks Analyst Blog Highlights: Costco, ExxonMobil, Bristol-Myers, Shire and Darden
Oct-06-16 06:06PM  John Paulson's Health Care Stocks Drop Far Below Sector Return
03:00PM  Kyle Bass Is Frustrated by Shires Lialda Patent Ruling
01:26PM  Top Research Reports for Costco, Exxon & Bristol-Myers
06:30AM  Kamada Announces Extension of GLASSIA® Supply and Distribution Agreement with Shire with Minimum $237 Million of Revenue for the Years 2017 to 2020 GlobeNewswire
Oct-05-16 06:07PM  Patent Trial and Appeal Board Upholds the Validity of LIALDA® Patent PR Newswire
09:00AM  How Billionaire Dan Loebs Top New Picks Performed in Q3? at Insider Monkey
Oct-04-16 01:48PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
10:14AM  Stock Gains Fade; Downgrade Nicks GrubHub
09:42AM  Merrimack Pharma's CEO Exits; Layoffs Announced at Investopedia
Sep-30-16 02:45PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
08:34AM  Brean Likes Nektar Therapeutics' Upcoming Launches; Assumes Coverage At Buy
Sep-28-16 09:18AM  Momenta to Regain Rights to Humira Biosimilar from Shire
09:16AM  Blog Coverage Shire PLC Terminates Collaboration Agreement with Momenta Pharma for M923
Sep-27-16 07:10PM  Third Value Fund Avenue Buys 3 Stocks in 3rd Quarter
Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various products for the treatment of attention deficit hyperactivity disorder (ADHD), including VYVANSE/VENVANSE, a pro-drug stimulant; ELVANSE/TYVENSE; INTUNIV, an alpha-2A receptor agonist; EQUASYM, a methylphenidate hydrochloride; and ADDERALL XR, an extended release treatment for ADHD. The company also provides PENTASA and LIALDA/MEZAVANT for ulcerative colitis treatment; and RESOLOR, a 5-HT4 receptor agonist for oral symptomatic treatment of chronic constipation in women. In addition, it offers FOSRENOL, a phosphate binder for use in end-stage renal disease receiving dialysis; and XAGRID for the reduction of elevated platelet counts in at-risk essential thrombocythemia patients, as well as for the treatment of thrombocythemia. Further, the company provides REPLAGAL for the treatment of Fabry disease; ELAPRASE for the treatment of hunter syndrome; VPRIV for the treatment of type 1 Gaucher disease; and FIRAZYR for the symptomatic treatment of acute attacks of hereditary angioedema. Additionally, it offers FOSRENOL for the treatment of hyperphosphatemia in end stage renal disease; XAGRID for the reduction of elevated platelet counts; and CINRYZE, a C1 esterase inhibitor therapy for routine prophylaxis against hereditary angioedema. The company also licenses its patented antiviral products for human immunodeficiency virus and hepatitis B virus. Shire plc markets its products directly to government hospitals, clinics, pharmacies, and other agencies; and through wholesalers and distributors. The company sells its products in North America, the United Kingdom, the Republic of Ireland, and internationally. Shire plc has research collaboration with Santaris Pharma A/S. The company was founded in 1986 and is headquartered in Dublin, Ireland.
DAL Delta Air Lines, Inc. daily Stock Chart
DAL [NYSE]
Delta Air Lines, Inc.
IndexS&P 500 P/E7.73 EPS (ttm)6.18 Insider Own0.20% Shs Outstand740.54M Perf Week-1.38%
Market Cap35.41B Forward P/E9.14 EPS next Y5.23 Insider Trans-38.05% Shs Float740.54M Perf Month14.60%
Income4.73B PEG0.77 EPS next Q0.99 Inst Own82.90% Short Float2.20% Perf Quarter30.47%
Sales39.68B P/S0.89 EPS this Y621.80% Inst Trans-4.04% Short Ratio1.59